WO2023284645A1 - 一种酰胺类化合物及其用途 - Google Patents

一种酰胺类化合物及其用途 Download PDF

Info

Publication number
WO2023284645A1
WO2023284645A1 PCT/CN2022/104612 CN2022104612W WO2023284645A1 WO 2023284645 A1 WO2023284645 A1 WO 2023284645A1 CN 2022104612 W CN2022104612 W CN 2022104612W WO 2023284645 A1 WO2023284645 A1 WO 2023284645A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
propargyl
allyl
general formula
iii
Prior art date
Application number
PCT/CN2022/104612
Other languages
English (en)
French (fr)
Inventor
张立新
张静
裴鸿艳
康卓
Original Assignee
沈阳化工大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 沈阳化工大学 filed Critical 沈阳化工大学
Priority to AU2022310062A priority Critical patent/AU2022310062B2/en
Publication of WO2023284645A1 publication Critical patent/WO2023284645A1/zh
Priority to US18/410,006 priority patent/US20240199552A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/88—Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Definitions

  • the present invention relates to a compound, in particular to a novel amide compound and its use.
  • Patent JP2007099761A discloses the following specific compounds KC1 (CAS accession number: 934532-14-6) and KC2 (CAS accession number: 934532-15-7), which have certain insecticidal activity.
  • Patent CN102119143A discloses the following compounds with insecticidal activity KC3 (compound number: 7-1574, CAS accession number: 1207727-04-5), KC4 (compound number: 7-1577, CAS accession number: 1207727-08-9 ) and KC5 (compound number: 7-1733, CAS accession number: 1207727-07-8).
  • compound KC3 has been commercialized as an agricultural insecticide.
  • the Chinese common name is broflanilide, and the English common name is broflanilide.
  • Patent CN102119143A also discloses the following compounds with insecticidal activity KC6 (compound number: 6-1772, CAS accession number: 1331922-53-2), KC7 (compound number: 7-1616, CAS accession number: 1207979-50- 7) and KC8 (compound number: 7-1772, CAS accession number: 1332266-07-5).
  • compound KC6 is being developed as an insecticide, and its English common name is mivorilaner.
  • the object of the present invention is to provide an amide compound with excellent insecticidal activity. It can be used in the preparation of medicines for controlling pests in agriculture and other fields, and in the field of veterinary medicine for the preparation of medicines for controlling animal parasites.
  • the present invention provides following technical scheme:
  • R is selected from hydrogen, fluorine, cyano, trifluoromethyl or difluoromethyl ;
  • R is selected from allyl or propargyl ;
  • R 3 is selected from halogen
  • R 4 is selected from halogen, C 1 -C 3 haloalkyl or C 1 -C 3 haloalkoxy;
  • X is selected from CH or N.
  • R is selected from hydrogen, fluorine, cyano, trifluoromethyl or difluoromethyl ;
  • R is selected from allyl or propargyl ;
  • R is selected from bromine or iodine
  • R is selected from bromo, iodo, trifluoromethyl or difluoromethoxy ;
  • X is selected from CH or N.
  • the amide compound is selected from the compounds in Table 1, the compound in Table 1 has a structure such as general formula I and R 1 , X, R 2 , R 3 and R 4 are as shown in Table 1 :
  • the amide compound is selected from the compounds in Table 2, the compound in Table 2 has a structure such as general formula I and R 1 , X, R 2 , R 3 and R 4 are as shown in Table 2 :
  • the amide compound is selected from the compounds in Table 3, the compound in Table 3 has a structure such as general formula I and R 1 , X, R 2 , R 3 and R 4 are as shown in Table 3 :
  • the present invention also includes an intermediate compound for the preparation of the above-mentioned amide compound (i.e. compound of general formula I), said intermediate compound is shown in general formula II:
  • R is selected from hydrogen, fluorine, cyano, trifluoromethyl or difluoromethyl ;
  • R is selected from allyl or propargyl ;
  • X is selected from CH or N.
  • the intermediate compound is selected from the compounds of Table 4, the compound of Table 4 has a structure such as general formula II and R 1 , X and R 2 are as shown in Table 4:
  • the present invention also includes an intermediate compound for preparing the above-mentioned compound of general formula II, said intermediate compound is shown in general formula III:
  • R is selected from hydrogen, fluorine, cyano, trifluoromethyl or difluoromethyl ;
  • X is selected from CH or N;
  • R is selected from allyl or propargyl ;
  • R 5 is selected from C 1 -C 6 alkyl.
  • the intermediate compound is selected from the compounds in Table 5, the compound in Table 5 has a structure such as general formula III and R 1 , X, R 2 and R 5 are as shown in Table 5:
  • the present invention also includes an intermediate compound for preparing the above-mentioned compound of general formula III, said intermediate compound is shown in general formula IV:
  • R is selected from allyl or propargyl ;
  • R 5 is selected from C 1 -C 6 alkyl.
  • the intermediate compound is selected from the compounds in Table 6, the compounds in Table 6 have a structure such as general formula IV and R 2 and R 5 are as shown in Table 6:
  • the present invention also includes an intermediate compound for the preparation of the above-mentioned amide compound (i.e. the compound of general formula I), said intermediate compound is shown in general formula V:
  • R is selected from allyl or propargyl ;
  • R 3 is selected from halogen
  • R 4 is selected from halogen, C 1 -C 3 haloalkyl or C 1 -C 3 haloalkoxy.
  • R is selected from allyl or propargyl ;
  • R is selected from bromine or iodine
  • R4 is selected from bromo, iodo, trifluoromethyl or difluoromethoxy.
  • the intermediate compound is selected from the compounds in Table 7, the compound in Table 7 has a structure such as general formula V and R 2 , R 3 and R 4 are as shown in Table 7:
  • the intermediate compound is selected from the compounds in Table 8, the compound in Table 8 has a structure such as general formula V and R 2 , R 3 and R 4 are as shown in Table 8:
  • the present invention also includes an intermediate compound for the preparation of the above-mentioned amide compound (i.e. the compound of general formula I), said intermediate compound is shown in general formula VI:
  • R is selected from hydrogen, fluorine, cyano, trifluoromethyl or difluoromethyl ;
  • R is selected from allyl or propargyl ;
  • R 4 is selected from halogen, C 1 -C 3 haloalkyl or C 1 -C 3 haloalkoxy;
  • X is selected from CH or N.
  • R is selected from hydrogen, fluorine, cyano, trifluoromethyl or difluoromethyl ;
  • R is selected from allyl or propargyl ;
  • R is selected from bromo, iodo, trifluoromethyl or difluoromethoxy ;
  • X is selected from CH or N.
  • the intermediate compound is selected from the compounds in Table 9, the compound in Table 9 has a structure such as general formula VI and R 1 , X, R 2 and R 4 are as shown in Table 9:
  • the intermediate compound is selected from the compounds in Table 10, the compound in Table 10 has a structure such as general formula VI and R 1 , X, R 2 and R 4 are as shown in Table 10:
  • the present invention also includes an intermediate compound for preparing the compound of the above-mentioned general formula VI, the intermediate compound is shown in the general formula VII:
  • R is selected from allyl or propargyl ;
  • R 4 is selected from halogen, C 1 -C 3 haloalkyl or C 1 -C 3 haloalkoxy.
  • R is selected from allyl or propargyl ;
  • R4 is selected from bromo, iodo, trifluoromethyl or difluoromethoxy.
  • the intermediate compound is selected from the compounds in Table 11, the compound in Table 11 has a structure such as general formula VII and R 2 and R 4 are as shown in Table 11:
  • the compound of general formula IV can be prepared by reacting the compound of general formula VIII with the compound of general formula R 2 -LG in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base.
  • the compound of general formula IV can be prepared by reacting the compound of general formula IV with the compound of general formula IX in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • the compound of the general formula III can be hydrolyzed to obtain the compound of the general formula II at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours;
  • a suitable base can be lithium hydroxide, sodium hydroxide, potassium hydroxide, Sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, mixture of lithium bromide and triethylamine, mixture of sodium bromide and triethylamine;
  • suitable solvents are water, methanol, ethanol, tetrahydrofuran or dioxane Any one or a mixed solvent of at least two alkanes.
  • the compound of general formula X can be prepared by reacting the compound of general formula II with thionyl chloride, oxalyl chloride, carbonyl chloride, phosphorus oxychloride, phosphorus pentachloride, phosphorus trichloride, triphosgene, etc. by conventional methods.
  • the compound of general formula I can be prepared by reacting the compound of general formula X with the compound of general formula XI in a suitable solvent at a temperature ranging from -70°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • suitable solvents can be aromatic hydrocarbons such as benzene, toluene and xylene, ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, halogenated hydrocarbons such as chloroform and methylene chloride, Esters such as methyl acetate and ethyl acetate, ethers such as tetrahydrofuran, dioxane, diethyl ether, and 1,2-dimethoxyethane, water, acetonitrile, N,N-dimethylformamide, N- Polar solvents such as methylpyrrolidone and dimethyl sulfoxide, or mixed solvents of the above solvents; the bases can be the same or different, such as trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, N,N- Organic bases such as diisopropylmethylamine and N,N-di
  • Alkaline earth metal hydroxides alkali metal carbonates such as sodium carbonate and potassium carbonate, alkali metal bicarbonates such as sodium bicarbonate, metal alcohols such as sodium methoxide, sodium ethoxide, potassium ethoxide, potassium tert-butoxide, and sodium tert-butoxide Salt; the same or different catalysts are potassium iodide, sodium iodide, potassium fluoride, sodium fluoride, potassium bromide or sodium bromide, etc.
  • the compound of the general formula XI can be prepared by reacting the compound of the general formula XII with 2-fluoro-3-nitrobenzoyl chloride in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and reacting in a base or a catalyst in presence.
  • the compound of general formula XII is prepared by reduction reaction to the compound of general formula XIII.
  • a method using a hydrogenation reaction and a method using a metal compound (such as stannous chloride) or a metal (zinc powder, iron powder, etc.) can be cited.
  • the method utilizing hydrogenation reaction can be carried out in a suitable solvent, in the presence of a catalyst, under normal pressure or under increased pressure, and carry out the reaction in a hydrogen atmosphere.
  • a catalyst in the hydrogenation reaction, palladium catalysts such as palladium-carbon, cobalt catalysts, rhodium catalysts, platinum catalysts and the like can be used.
  • the solvent include alcohols such as methanol and ethanol; aromatic hydrocarbons such as benzene and toluene; chain or cyclic ethers such as acetaldehyde and tetrahydrofuran; and esters such as ethyl acetate.
  • the pressure of the hydrogenation reaction is 0.1-10MPa, such as 0.1MPa, 0.5MPa, 0.8MPa, 1MPa, 1.5MPa, 2MPa, 3MPa, 4MPa, 5MPa, 6MPa, 7MPa, 8MPa, 9MPa or 10MPa.
  • the temperature of the hydrogenation reaction is greater than or equal to -20°C and less than or equal to the boiling point of the reaction solvent, such as -20°C, -10°C, -5°C, 0°C, 5°C, 10°C, 15°C, 20°C , 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • the boiling point of the reaction solvent such as -20°C, -10°C, -5°C, 0°C, 5°C, 10°C, 15°C, 20°C , 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • the time of the hydrogenation reaction is 0.5-48 hours, such as 0.5 hours, 1 hour, 3 hours, 5 hours, 8 hours, 10 hours, 12 hours, 15 hours, 18 hours, 20 hours, 23 hours, 25 hours Hours, 28 hours, 30 hours, 33 hours, 35 hours, 38 hours, 40 hours, 44 hours or 48 hours.
  • the method using metal compounds or metals is carried out in any one or a mixed solvent of at least two of methanol, ethanol or ethyl acetate.
  • the metal compound is stannous chloride, and the metal is any one or a combination of at least two of zinc powder or iron powder.
  • the reaction temperature of the method using a metal compound or metal is greater than or equal to -10°C and less than or equal to the boiling point of the reaction solvent, such as -10°C, -5°C, 0°C, 5°C, 10°C, 15°C , 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • the boiling point of the reaction solvent such as -10°C, -5°C, 0°C, 5°C, 10°C, 15°C , 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • the reaction time of the metal compound or metal method is 0.5-48 hours, such as 0.5 hours, 1 hour, 3 hours, 5 hours, 8 hours, 10 hours, 12 hours, 15 hours, 18 hours, 20 hours, 23 hours, 25 hours, 28 hours, 30 hours, 33 hours, 35 hours, 38 hours, 40 hours, 44 hours or 48 hours.
  • the compound of general formula V can be prepared by reacting the compound of general formula XIII with the compound of general formula R 2 -LG in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • the compound of general formula I can be prepared by reacting the compound of general formula V with the compound of general formula IX in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • suitable solvents can be the same or different aromatic hydrocarbons such as benzene, toluene, xylene, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, halogens such as chloroform and dichloromethane, etc.
  • Substituted hydrocarbons methyl acetate, ethyl acetate and other esters, tetrahydrofuran, dioxane, diethyl ether, 1,2-dimethoxyethane and other ethers, water, acetonitrile, N,N-dimethylformaldehyde Amide, N-methylpyrrolidone, dimethyl sulfoxide and other polar solvents or mixed solvents of the above solvents;
  • the base can be the same or different as trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, Organic bases such as N,N-diisopropylmethylamine and N,N-diisopropylethylamine, alkali metal hydrides such as sodium hydride and potassium hydride, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, Alkaline earth metal hydroxides such as calcium hydroxide, alkali metal carbonates such
  • Suitable solvents are aromatic hydrocarbons such as benzene, toluene, and xylene, ketones such as acetone, methyl ethyl ketone, and methyl isobutyl ketone, halogenated hydrocarbons such as chloroform and methylene chloride, and esters such as methyl acetate and ethyl acetate.
  • the bases can be the same or different: trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, N,N-diisopropylmethylamine, N,N - Organic bases such as diisopropylethylamine, alkali metal hydrides such as sodium hydride and potassium hydride, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkaline earth metal hydroxides such as calcium hydroxide, sodium carbonate, Alkali metal carbonates such as potassium carbonate, alkali metal bicarbonates such as sodium bicarbonate, metal alkoxides such as sodium methoxide, sodium ethoxide, potassium ethoxide, potassium tert-butoxide, sodium tert-butoxide; the catalyst can be the same or different as potassium iodide , sodium iodide, potassium fluoride, sodium fluoride, potassium bromide or sodium bromide;
  • the compound of general formula I can be prepared by reacting the compound of general formula VI with a suitable halogenating reagent in a suitable solvent.
  • the reaction usually requires the participation of a suitable base, and the suitable base can be selected from trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, N,N-diisopropylmethylamine, N,N-diisopropyl ethylamine, sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium methoxide, sodium ethoxide, potassium ethoxide, potassium tert-butoxide or Sodium tert-butoxide; preferably sodium hydride, potassium hydride, sodium hydroxide or potassium hydroxide.
  • the suitable base can be selected from trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, N,N-diisopropylmethylamine, N,N-diisopropyl ethylamine, sodium
  • Suitable halogenating reagents are selected from chlorine gas, liquid bromine, iodine, NBS, NCS, NIS, a mixture of hydrogen peroxide and hydrobromic acid, a mixture of hydrogen peroxide and hydroiodic acid, a mixture of sodium hypochlorite and hydrobromic acid, a mixture of sodium hypochlorite and hydroiodic acid mixture, a mixture of sodium chlorate and hydrobromic acid, or a mixture of sodium chlorate and hydroiodic acid.
  • Suitable solvents are selected from benzene, toluene, xylene, acetone, methyl ethyl ketone, methyl isobutyl ketone, chloroform, dichloromethane, methyl acetate, ethyl acetate, tetrahydrofuran, dioxane, diethyl ether, 1,2- Dimethoxyethane, water, acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, dimethyl sulfoxide or a mixed solvent of the above solvents.
  • the reaction temperature is from -10°C to the boiling point of the selected solvent; the preferred reaction temperature is 0°C-100°C, more preferably 25°C-80°C.
  • the reaction time is 0.5-48 hours, preferably 1-10 hours.
  • the compound of the general formula XIV can be prepared by reacting the compound of the general formula XIV with 2-fluoro-3-nitrobenzoyl chloride in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and reacting in a base or a catalyst in presence.
  • the compound of general formula XV can be prepared by reduction reaction to obtain the compound of general formula XVI.
  • a method using a hydrogenation reaction and a method using a metal compound (such as stannous chloride) or a metal (zinc powder, iron powder, etc.) can be cited.
  • the method utilizing hydrogenation reaction can be carried out in a suitable solvent, in the presence of a catalyst, under normal pressure or under increased pressure, and carry out the reaction in a hydrogen atmosphere.
  • a catalyst in the hydrogenation reaction, palladium catalysts such as palladium-carbon, cobalt catalysts, rhodium catalysts, platinum catalysts and the like can be used.
  • the solvent include alcohols such as methanol and ethanol; aromatic hydrocarbons such as benzene and toluene; chain or cyclic ethers such as acetaldehyde and tetrahydrofuran; and esters such as ethyl acetate.
  • the pressure of the hydrogenation reaction is 0.1-10MPa, such as 0.1MPa, 0.5MPa, 0.8MPa, 1MPa, 1.5MPa, 2MPa, 3MPa, 4MPa, 5MPa, 6MPa, 7MPa, 8MPa, 9MPa or 10MPa.
  • the temperature of the hydrogenation reaction is greater than or equal to -20°C and less than or equal to the boiling point of the reaction solvent, such as -20°C, -10°C, -5°C, 0°C, 5°C, 10°C, 15°C, 20°C , 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • the boiling point of the reaction solvent such as -20°C, -10°C, -5°C, 0°C, 5°C, 10°C, 15°C, 20°C , 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • the time of the hydrogenation reaction is 0.5-48 hours, such as 0.5 hours, 1 hour, 3 hours, 5 hours, 8 hours, 10 hours, 12 hours, 15 hours, 18 hours, 20 hours, 23 hours, 25 hours Hours, 28 hours, 30 hours, 33 hours, 35 hours, 38 hours, 40 hours, 44 hours or 48 hours.
  • the method using metal compounds or metals is carried out in any one or a mixed solvent of at least two of methanol, ethanol or ethyl acetate.
  • the metal compound is stannous chloride, and the metal is any one or a combination of at least two of zinc powder or iron powder.
  • the reaction temperature of the method using a metal compound or metal is greater than or equal to -10°C and less than or equal to the boiling point of the reaction solvent, such as -10°C, -5°C, 0°C, 5°C, 10°C, 15°C , 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • the boiling point of the reaction solvent such as -10°C, -5°C, 0°C, 5°C, 10°C, 15°C , 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 75°C, 80°C, etc., or react at the boiling point of the solvent, that is, under reflux.
  • reaction time of the method using metal compound or metal is 0.5-48 hours
  • the compound of general formula VII can be prepared by reacting the compound of general formula XVI with the compound of general formula R 2 -LG in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • the compound of the general formula VI can be prepared by reacting the compound of the general formula VII with the compound of the general formula IX in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • suitable solvents can be the same or different aromatic hydrocarbons such as benzene, toluene, xylene, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, halogens such as chloroform and dichloromethane, etc.
  • Substituted hydrocarbons methyl acetate, ethyl acetate and other esters, tetrahydrofuran, dioxane, diethyl ether, 1,2-dimethoxyethane and other ethers, water, acetonitrile, N,N-dimethylformaldehyde Amide, N-methylpyrrolidone, dimethyl sulfoxide and other polar solvents or mixed solvents of the above solvents;
  • the base can be the same or different as trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, Organic bases such as N,N-diisopropylmethylamine and N,N-diisopropylethylamine, alkali metal hydrides such as sodium hydride and potassium hydride, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, Alkaline earth metal hydroxides such as calcium hydroxide, alkali metal carbonates such
  • the compound of general formula XVII can be prepared by reacting the compound of general formula VIII with the compound of general formula IX in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • the compound of general formula III can be prepared by reacting the compound of general formula XVII with the compound of general formula R 2 -LG in a suitable solvent at a temperature ranging from -10°C to the boiling point of the solvent for 0.5-48 hours, and the reaction is carried out in the presence of a base or a catalyst.
  • suitable solvents can be the same or different aromatic hydrocarbons such as benzene, toluene and xylene, ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, halogenated hydrocarbons such as chloroform and methylene chloride , methyl acetate, ethyl acetate and other esters, tetrahydrofuran, dioxane, diethyl ether, 1,2-dimethoxyethane and other ethers, water, acetonitrile, N,N-dimethylformamide, N -Polar solvents such as methylpyrrolidone and dimethyl sulfoxide, or mixed solvents of the above solvents;
  • the bases can be the same or different, such as trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, N,N -Organic bases such as diisopropylmethylamine
  • the embodiment of the present invention also provides the use of the above amide compounds in the preparation of insecticides.
  • the insecticide is used to control one or more of the following insects: beetles (Coleopteran), such as mung bean elephant (Callosobruchus Chinensis), corn elephant (Sitophilus zeamais) , Tribolium Castaneum, Epilachna vigintioctomaculata, Agriotes ogurae fuscicollis, Anomala rufocuprea, Leptinotarsa decemlineata, Leptinotarsa decemlineata ( Diabrotica spp.), Monochamus alternatus endai, Lissorhoptrus oryzophilus, Lyctus bruneus;
  • Lepidopteran pests such as Lymantria dispar, Malacosoma neustria, Pieris rapae crucivora, Spodoptera litura, Mamestra brassicae), Chilo suppressalis, Ostrinia nubilalis, Cadra cautella, chyanokokakumonhamaki (Adoxophyes honmai), Cydia pomonella, Agrotis segetum, Greater wax moth (Galleria mellonella), diamondback moth (Plutella xylostella), tobacco bud moth (Heliothis virescens), orange miner moth (Phyllocnistis citrella);
  • Pests of the order Hemipterous e.g. Nephotettix cincticeps, Nilaparvata lugens, Pseudococcus comstocki, Unaspis yanonensis, Myzus persicas, Apple aphid (Aphis pomi), cotton aphid (Aphis gossypii), turnip aphid (Lipaphis erysimi), pear crown bug (Stephanitis nashi), green twig (Nezara spp.), greenhouse whitefly (Trialeurodes vaporariorum), Pshylla spp. ;
  • Thysanoptera such as Thrips palmi, Franklinella occidentalis
  • Orthopteran pests such as African mole cricket (Gryllotalpa Africana), African locust (Locusta migratoria);
  • pests of the order of the blattarian such as Blattella germanica, Periplaneta americana, Reticulitermes speratus, Coptotermes formosanus;
  • Dipterous pests such as Musca domestica, Aedes aegypti, Delia platura, Culex pipiens pallens, Anopheles sinensis, Culex tritaeniorhynchus, Liriomyza trifolii, etc.
  • Agricultural pest mites such as Tetranychus cinnabarinus, Tetrahychus urticae, Panonychus citri, Aculops pelekassi, Tarsonemus spp., etc. .
  • the insecticide is used to control one or more of diamondback moth, armyworm, beet armyworm, Spodoptera litura, Chiloborer, peach aphid, thrips, flea beetle .
  • the embodiment of the present invention also provides an insecticide preparation, which contains the above-mentioned amide compound as an active component, and also contains one or more auxiliary materials.
  • the insecticide preparation is selected from the following dosage forms: solution, emulsion, wettable powder, granular wettable powder, suspension, powder (powder), foam, ointment, tablet, granule medicaments, aerosols, natural agents impregnated with active compounds, synthetic agents impregnated with active compounds, microcapsules, seed coatings, preparations equipped with combustion devices (the combustion devices can be chimneys and mist cylinders, tanks and coils, etc.) and ULV (cold fog, hot fog) and so on.
  • combustion devices can be chimneys and mist cylinders, tanks and coils, etc.
  • ULV cold fog, hot fog
  • insecticide formulations or animal parasite control agents can be prepared by known methods, for example, by combining the active ingredient with a filler (such as: liquid diluent or carrier, liquefied gas diluent or carrier, solid diluent or carrier) Mixed, and optionally mixed with surfactants (ie, emulsifiers and/or dispersants and/or foaming agents) and the like.
  • a filler such as: liquid diluent or carrier, liquefied gas diluent or carrier, solid diluent or carrier
  • surfactants ie, emulsifiers and/or dispersants and/or foaming agents
  • the auxiliary material includes one or more of the following: filler (such as: liquid diluent or carrier, liquefied gas diluent or carrier, solid diluent or carrier), surfactant (such as: emulsifiers and/or dispersants and/or foaming agents), binders, colorants;
  • filler such as: liquid diluent or carrier, liquefied gas diluent or carrier, solid diluent or carrier
  • surfactant such as: emulsifiers and/or dispersants and/or foaming agents
  • binders such as: binders, colorants;
  • Liquid diluents or carriers may include, for example, aromatic hydrocarbons (xylene, toluene, alkylnaphthalene, etc.), chlorinated aromatic hydrocarbons or chlorinated aliphatic hydrocarbons (e.g., chlorobenzene, vinyl chloride, methylene chloride, etc.), aliphatic hydrocarbons (such as cyclohexane or paraffins (such as mineral oil fractions)), alcohols (such as butanol, ethylene glycol, and their ethers or esters, etc.), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone , cyclohexanone, etc.), strong polar solvents (such as dimethylformamide, dimethyl sulfoxide), water, etc.
  • aromatic hydrocarbons xylene, toluene, alkylnaphthalene, etc.
  • Liquefied gas diluents or carriers may include those that exist in gaseous form at atmospheric pressure and temperature, for example, propane, nitrogen, carbon dioxide, and aerosol propellants such as halogenated hydrocarbons;
  • Solid diluents may include comminuted natural minerals such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite, or diatomaceous earth, as well as comminuted synthetic minerals such as finely divided silicic acid, alumina and silicates, etc.);
  • Emulsifiers and/or foaming agents may include nonionic and anionic emulsifiers [for example, polyoxyethylene fatty acid esters, polyoxyethylene fatty acid alcohol ethers (such as alkyl aryl polyglycol ethers), alkyl sulfonates , alkyl sulfate and aryl sulfonate] and albumin hydrolyzate, etc.;
  • nonionic and anionic emulsifiers for example, polyoxyethylene fatty acid esters, polyoxyethylene fatty acid alcohol ethers (such as alkyl aryl polyglycol ethers), alkyl sulfonates , alkyl sulfate and aryl sulfonate] and albumin hydrolyzate, etc.;
  • Dispersants may include lignin sulfite waste liquor and methyl cellulose;
  • Binders may include carboxymethylcellulose, natural or synthetic polymers (such as gum arabic, polyvinyl alcohol and polyvinyl acetate, etc.);
  • Colorants may include inorganic pigments (such as iron oxide, titanium oxide and Prussian blue, etc.), organic dyes such as alizarin dyes, azo dyes or metal phthalocyanine dyes; and trace elements such as iron salts, manganese salts, boron salts, copper salt, cobalt salt, molybdenum salt or zinc salt.
  • inorganic pigments such as iron oxide, titanium oxide and Prussian blue, etc.
  • organic dyes such as alizarin dyes, azo dyes or metal phthalocyanine dyes
  • trace elements such as iron salts, manganese salts, boron salts, copper salt, cobalt salt, molybdenum salt or zinc salt.
  • the amides according to the invention may be present in admixture with a synergist, which need not be active itself. Rather, it is a compound that enhances the activity of the active compound.
  • the amount of the above amide compound contained in the insecticide formulation is 0.1 to 99% by weight, optionally 0.5 to 90% by weight.
  • Embodiments of the present invention also provide an insecticide composition, which includes the above-mentioned amide compounds and other active compounds (such as insecticides, poison baits, disinfectants, acaricides, nematocides, fungicides, growth regulators, herbicides, etc.).
  • the mixture may be provided in the form of a raw drug, or in the form of a commercially available preparation or a use form prepared from the preparation thereof.
  • the embodiment of the present invention also provides a method for controlling agricultural or forestry pests, which includes the following steps: applying an effective dose of material to the pests to be controlled or their growth medium, the material is selected from one of the following groups or more: the above-mentioned amide compound, the above-mentioned insecticide preparation, and the above-mentioned insecticide composition.
  • the embodiment of the present invention also provides the use of the above amide compounds in the preparation of animal parasite control agents.
  • the amides of the invention can be used effectively against a wide variety of harmful animal parasites, especially endoparasites and ectoparasites.
  • animal parasites include one or more of the following:
  • Anoplurida for example Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp and Solenopotes spp.; in particular, representative examples Yes, Linognathus setosus, Solenopotes capillatus;
  • Trichophagous (Mallophah, Linognathus vituli), Sheep jaw louse (Linognathus ovillus), Linognathus oviformis, Foot jaw louse (Linognathus pedalis), Goat jaw louse (Linognathus stenopsis), Donkey blood louse (Haematopinus asini macrocephalus), Blood lice (Haematopinus eurysternus), blood lice (Haematopinus suis), head lice (Pediculus humanus capitis), body lice (Pediculus humanus corporis), grape phylloxera (Phylloera vastatrix), pubic lice (Phthirus pubis) gida) and obtuse suborders Amblycerina and Ischnocerin, e.g.
  • Trimenopon spp. Menopon spp., Trinoton spp., Bovicola spp.), Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp., and Felicola spp.; in particular, representative examples are, bovine hair lice (Bovicola bovis), Wool louse (Bovicola ovis), Angora goat feather louse (Bovicola limbata), Cattle louse (Damalina bovis), Dog hair louse (Trichodectes canis), Cat feather louse (Felicola subrostratus), Goat hair louse (Bovicola caprae) , Lepikentron ovis, biting lice (Werneckiella equi);
  • Nematocerina and Brachycerina From the order Diptera and its suborders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp .), Simulium spp, Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp.
  • Chrysops spp. Odagmia spp., Wilhelmia spp., Hybomitra spp., Atylotus spp., Tabanus spp., Hemp Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia ( Lucilia spp.), Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Stomach Gasterophilus spp., Hippobosca spp., Lipoptena spp., Melophagus spp., Rhino
  • Ctenocephalides canis Ctenocephalides felis, Pulex irritans, Tunga penetrans, Ctenocephalides felis (Xenopsylla cheopis);
  • Metastigmata and Mesostigmata e.g., Argas spp., Ornithodorus spp., Ticks Otobius spp., Ixodes spp., Amblyomma spp., Rhipicephalus (Boophilus) spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Dermanyssus spp., Rhipicephalus spp.
  • Actinedida Prostigmata
  • Acaridida Acaridida
  • Acarapis spp. Cheyletiella spp.
  • Ornitrocheyletia spp. Ornitrocheyletia spp.
  • Myobia spp. Psorergates spp.
  • Demodex spp. Trombicula spp.
  • Sarcoptes equi Sarcoptes su is
  • Psoroptes ovis Psoroptes cuniculi
  • Psoroptes equi Chorioptes bovis
  • Psoergates ovis Pneumonyssoidic mange
  • Pneumonyssoides caninum, Acarapis woodi;
  • Nematodes such as Meloidogyne incognita, Bursaphelenchus xylophilus, Aphelenchoides besseyi, Heterodera glycines, Pratylenchus spp. and the like.
  • Arthropods, helminths and malaria parasites that attack animals. Control of arthropods, helminths and/or malaria parasites reduces mortality in domesticated animals and improves animal productivity (meat, milk, fur, hides, eggs and honey) and health.
  • the animal parasite control agent is used to control one or more of cat fleas and American dog ticks.
  • the animals include one or more of the following: agricultural animals, such as cattle, sheep, goats, horses, pigs, donkeys, camels, buffaloes, rabbits, chickens, turkeys, ducks, geese , farmed fish, bees, etc.; pets known as companion animals, such as dogs, cats, cage birds, ornamental fish; and animals used in experiments, such as hamsters, guinea pigs, rats, and mice.
  • agricultural animals such as cattle, sheep, goats, horses, pigs, donkeys, camels, buffaloes, rabbits, chickens, turkeys, ducks, geese , farmed fish, bees, etc.
  • companion animals such as dogs, cats, cage birds, ornamental fish
  • animals used in experiments such as hamsters, guinea pigs, rats, and mice.
  • the embodiment of the present invention also provides an animal parasite control agent, which contains the above-mentioned amide compound as an active component, and also contains one or more auxiliary materials.
  • the animal parasite control agent is selected from the following dosage forms: tablets, capsules, drinks, drinkable medicines, granules, ointments and pills, suppositories, injections (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.), paints, aerosols, non-pressurized sprays (such as pump sprays and atomized sprays).
  • the amount of the above-mentioned active components contained in the animal parasite control agent is in an amount of 1 to 80% by weight.
  • Embodiments of the present invention also provide a composition for preventing and controlling animal parasites, which includes the above-mentioned amide compounds and other active compounds for preventing and controlling animal parasites (such as acaricides, insecticides, parasiticides, antimalarial agents, etc. )mixture.
  • the mixture may be provided in the form of a bulk drug, or in the form of a commercially available preparation or a use form prepared from the preparation thereof.
  • the embodiment of the present invention also provides a method for controlling animal parasites, which includes the following steps: applying an effective dose of material to the animal parasites to be controlled or its growth medium, the material is selected from one of the following groups One or more kinds: the above-mentioned amide compound; the above-mentioned animal parasite control agent; the above-mentioned animal parasite control composition.
  • enteral administration using tablets, capsules, drinks, drinkables, granules, ointments, pills, suppositories parenteral administration based on skin application, such as injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.), implantation, nasal administration, including bathing or soaking, spraying, pouring, dripping, washing and dusting, and through the use of model articles containing the active compound, such as collars, ear tags, tags, leg Use with leg braces, nets, markers, etc.
  • the active compounds of the present invention have low toxicity and can be safely administered to warm-blooded animals.
  • the amide compound of the present invention has an unexpectedly excellent insecticidal effect, it also exhibits a suitable control effect on poisonous pests, and it has no phytotoxicity to cultivated crop plants. Furthermore, the compounds of the present invention are useful for controlling various pests, such as harmful sucking insects, chewing insects and other plant parasitic pests, stored grain pests, hygiene pests, etc., and for disinfecting and killing them.
  • Halogen refers to fluorine, chlorine, bromine or iodine.
  • Haloalkyl straight chain or branched chain alkyl, the hydrogen atoms on these alkyl groups can be partially or completely replaced by halogen, such as difluoromethyl (CHF 2 ), trifluoromethyl (CF 3 ), etc.
  • Halogenated alkoxy the hydrogen atoms on the alkoxy can be partially or completely replaced by halogen, such as difluoromethoxy (OCHF 2 ), trifluoromethoxy (OCF 3 ), etc.
  • Insecticide A substance that has an insecticidal effect on pests.
  • Animal parasite control agent refers to an active compound that can effectively reduce the incidence of various parasites in parasite-infected animals. Control means that the active compound is effective to kill, inhibit the growth or reproduction of the parasite.
  • Embodiment 1 the preparation of intermediate compound II.7
  • Embodiment 2 the preparation of intermediate compound V.3
  • intermediate compound V.3 The NMR and mass spectrum data of intermediate compound V.3 are as follows:
  • Embodiment 3 the preparation of intermediate compound V.4
  • intermediate compound V.4 The NMR and mass spectrum data of intermediate compound V.4 are as follows:
  • Embodiment 4 the preparation of intermediate compound V.9
  • Embodiment 5 the preparation of intermediate compound V.10
  • Embodiment 6 the preparation of compound 7
  • Embodiment 7 the preparation of compound 8
  • Embodiment 8 the preparation of compound 19
  • Embodiment 9 the preparation of compound 20
  • Embodiment 10 the preparation of compound 31
  • Embodiment 11 Preparation of compound 36
  • Embodiment 12 the preparation of compound 47
  • Embodiment 13 Preparation of compound 48
  • Embodiment 14 Determination of insecticidal biological activity
  • Target armyworm Diamondback moth, Chilo suppressalis, beet armyworm, green peach aphid and western flower thrips were used to measure the activity by Airbrush spray method.
  • Measuring method cut corn leaves into 2cm-long leaf segments, spray the airbrush at a pressure of 10psi (about 0.7kg/cm 2 ), spray the front and back sides of each leaf segment, and spray 0.5mL of the compound to be tested. After drying in the shade, 10 third-instar larvae were inoculated into each treatment, and each treatment was repeated 3 times. After treatment, put them in an observation room at 25°C and a relative humidity of 60-70% for cultivation, and investigate the number of surviving insects 3 days after the treatment, and calculate the mortality rate.
  • Measuring method the cabbage leaves are punched into leaf discs with a diameter of 2cm, the pressure of the Airbrush spray treatment is 10psi (about 0.7kg/cm 2 ), the front and back sides of each leaf disc are sprayed, and the spray volume of the compound to be tested is 0.5mL. After drying in the shade, 10 third-instar larvae were inoculated into each treatment, and each treatment was repeated 3 times. After treatment, put them in an observation room at 25°C and a relative humidity of 60-70% for cultivation, investigate the number of surviving insects 3 days after treatment, and calculate the mortality rate.
  • KC9 and KC10 in the table are reference compounds provided by the application, which can be obtained by referring to the method of Example 10 of the present invention. be made of.
  • the compound of the present invention has an unexpected high Insecticidal activity and substantial progress.
  • test results are shown in Table 13.
  • Measuring method 1) Preparation of rice seedlings: Cultivate rice in a constant temperature room (temperature 26-28°C, relative humidity 60-80%, light 16hL:8hD) with a small plastic cup with a diameter of 4.5cm and a height of 4cm. At the 4-5 leaf stage, robust rice seedlings with consistent growth were selected for chemical treatment, and each treatment was repeated 3 times. 2) Preparation of test insects: 3rd instar larvae of Chilo borer continuously reared indoors. 3) The rice stems are sprayed with insects. Using the spraying method, the rice seedlings were uniformly sprayed on the whole plant, and 15 mL of medicine was used for each treatment.
  • the rice seedlings were sprayed they were placed in a cool place to dry the medicinal liquid, and the stalks about 5 cm above the base of the stems were cut and fed to the test insects.
  • compounds 3, 4, 7, 8, 11, 12, 19, 20, 23, 24, 27, 28, 31, 32, 35, 36, 39, 40, 47, 48, 51 , 52, 55, and 56 have a lethality rate of over 90% for Chilo borer.
  • Determination method The activity test was carried out by feeding with dipped leaf dish. Immerse the leaf discs in the liquid medicine for 10 seconds, dry them and place them in petri dishes, 4 discs per dish, and put filter paper in the petri dishes to keep them moist. Each plate received 10 beet armyworm test insects, repeated 3 times. Place in a light incubator at a temperature of 25°C and light of 14hL:10hD for cultivation. 1 day, 2 days, and 3 days after treatment, the number of dead beet armyworms was investigated, and the mortality rate was calculated.
  • Measuring method Take a 6cm diameter petri dish, cover the bottom of the dish with a layer of filter paper, and add an appropriate amount of tap water to moisturize it. Cut cabbage leaves with suitable size (about 3 cm in diameter) and 15 to 30 aphids from the cabbage plants for cultivating peach aphids, remove winged aphids and aphids on the front of the leaves, and place the leaves in a petri dish with the back facing up.
  • the pressure of the airbrush spray treatment is 10psi (approximately 0.7kg/cm2), the spray volume is 0.5mL, and each treatment is repeated 3 times. After treatment, put them in an observation room at 25°C and a relative humidity of 60-70% for cultivation. After 48 hours, investigate the number of surviving insects and calculate the mortality rate.
  • Determination method select fresh kidney bean leaves cultivated in the greenhouse, spray evenly with a hand-held Airbrush sprayer, 1 mL per treatment, dry in the shade naturally, place them in finger tubes, and insert neat and healthy nymphs of Thrips occidentalis, 15 heads per treatment, The experiment was repeated 3 times, and the water treatment was set as the blank control. After treatment, put them into a room with 24°C, 60%-70% relative humidity, and natural light for indoor cultivation. After 72 hours, investigate the number of surviving insects and calculate the mortality rate.
  • Embodiment 15 Insecticidal test to cat fleas
  • Embodiment 16 Insecticidal test to American dog tick
  • the inner wall of the petri dish used was 40 cm 2 , and the treatment dose was 1 ⁇ g/cm 2 . Put 10 first nymphs (mixed male and female) of T. americana into it, combine 2 petri dishes, seal the junction with tape to prevent escape, and store them in a constant temperature room at 25°C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Insects & Arthropods (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种酰胺类化合物及其用途，所述化合物结构如通式I所示：式中各取代基的定义见说明书；说明书中还公开了其作为杀虫剂和动物寄生虫防治剂的用途。

Description

一种酰胺类化合物及其用途 技术领域
本发明涉及一种化合物，具体涉及一种新型的酰胺类化合物及其用途。
背景技术
专利JP2007099761A中公开了如下具体化合物KC1(CAS登录号：934532-14-6)和KC2(CAS登录号：934532-15-7)，具有一定的杀虫活性。
Figure PCTCN2022104612-appb-000001
专利CN102119143A中公开了如下具有杀虫活性的化合物KC3(化合物序号：7-1574，CAS登录号：1207727-04-5)、KC4(化合物序号：7-1577，CAS登录号：1207727-08-9)及KC5(化合物序号：7-1733，CAS登录号：1207727-07-8)。其中化合物KC3作为农用杀虫剂已商品化，中文通用名为溴虫氟苯双酰胺，英文通用名为broflanilide。
Figure PCTCN2022104612-appb-000002
专利CN102119143A中还公开了如下具有杀虫活性的化合物KC6(化合物序号：6-1772，CAS登录号：1331922-53-2)、KC7(化合物序号：7-1616，CAS登录号：1207979-50-7)及KC8(化合物序号：7-1772，CAS登录号：1332266-07-5)。其中化合物KC6作为杀虫剂正在进行开发，其英文通用名为mivorilaner。
Figure PCTCN2022104612-appb-000003
然而，现有杀虫剂的防治效果仍然不够理想，仍需要不断开发新的、更高效、更广谱的杀虫剂以满足市场需求。
现有技术中如本发明通式I所示的化合物及其杀虫活性未见报道。
发明内容
本发明的目的在于提供一种杀虫活性优异的酰胺类化合物。它可用于制备农业和其它领域中防治害虫的药物以及在兽药领域用于制备控制动物寄生虫的药物。
为实现本发明的发明目的，本发明提供了如下技术方案：
一种酰胺类化合物，如通式I所示：
Figure PCTCN2022104612-appb-000004
通式I中：
R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
R 2选自烯丙基或炔丙基；
R 3选自卤素；
R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基；
X选自CH或N。
在一种可能的实现方式中，通式I中，
R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
R 2选自烯丙基或炔丙基；
R 3选自溴或碘；
R 4选自溴、碘、三氟甲基或二氟甲氧基；
X选自CH或N。
在一种可能的实现方式中，酰胺类化合物选自表1化合物，所述表1化合物具有如通式I的结构且R 1,X,R 2,R 3和R 4如表1中所示：
表1
Figure PCTCN2022104612-appb-000005
Figure PCTCN2022104612-appb-000006
Figure PCTCN2022104612-appb-000007
在一种可能的实现方式中，酰胺类化合物选自表2化合物，所述表2化合物具有如通式I的结构且R 1,X,R 2,R 3和R 4如表2中所示：
表2
Figure PCTCN2022104612-appb-000008
Figure PCTCN2022104612-appb-000009
在一种可能的实现方式中，酰胺类化合物选自表3化合物，所述表3化合物具有如通式I的结构且R 1,X,R 2,R 3和R 4如表3中所示：
表3
Figure PCTCN2022104612-appb-000010
Figure PCTCN2022104612-appb-000011
本发明还包括一种用于制备上述酰胺类化合物(即通式I化合物)的中间体化合物，所述中间体化合物如通式II所示：
Figure PCTCN2022104612-appb-000012
通式II中：
R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
R 2选自烯丙基或炔丙基；
X选自CH或N。
在一种可能的实现方式中，中间体化合物选自表4化合物，所述表4化合物具有如通式II的结构且R 1,X和R 2如表4中所示：
表4
化合物编号 R 1 X R 2
II.1 H CH 烯丙基
II.2 F CH 烯丙基
II.3 CN CH 烯丙基
II.4 F N 烯丙基
II.5 CN N 烯丙基
II.6 CF 3 N 烯丙基
II.7 H CH 炔丙基
II.8 F CH 炔丙基
II.9 CN CH 炔丙基
II.10 F N 炔丙基
II.11 CN N 炔丙基
II.12 CF 3 N 炔丙基
。
本发明还包括一种用于制备上述通式II化合物的中间体化合物，所述中间体化合物如通式III所示：
Figure PCTCN2022104612-appb-000013
通式III中：
R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
X选自CH或N；
R 2选自烯丙基或炔丙基；
R 5选自C 1-C 6烷基。
在一种可能的实现方式中，中间体化合物选自表5化合物，所述表5化合物具有如通式III的结构且R 1,X,R 2和R 5如表5中所示：
表5
化合物编号 R 1 X R 2 R 5
III.1 H CH 烯丙基 CH 3
III.2 F CH 烯丙基 CH 3
III.3 CN CH 烯丙基 CH 3
III.4 F N 烯丙基 CH 3
III.5 CN N 烯丙基 CH 3
III.6 CF 3 N 烯丙基 CH 3
III.7 H CH 炔丙基 CH 3
III.8 F CH 炔丙基 CH 3
III.9 CN CH 炔丙基 CH 3
III.10 F N 炔丙基 CH 3
III.11 CN N 炔丙基 CH 3
III.12 CF 3 N 炔丙基 CH 3
III.13 H CH 烯丙基 CH 2CH 3
III.14 F CH 烯丙基 CH 2CH 3
III.15 CN CH 烯丙基 CH 2CH 3
III.16 F N 烯丙基 CH 2CH 3
III.17 CN N 烯丙基 CH 2CH 3
III.18 CF 3 N 烯丙基 CH 2CH 3
III.19 H CH 炔丙基 CH 2CH 3
III.20 F CH 炔丙基 CH 2CH 3
III.21 CN CH 炔丙基 CH 2CH 3
III.22 F N 炔丙基 CH 2CH 3
III.23 CN N 炔丙基 CH 2CH 3
III.24 CF 3 N 炔丙基 CH 2CH 3
。
本发明还包括一种用于制备上述通式III化合物的中间体化合物，所述中间体化合物如通式IV所示：
Figure PCTCN2022104612-appb-000014
通式IV中：
R 2选自烯丙基或炔丙基；
R 5选自C 1-C 6烷基。
在一种可能的实现方式中，中间体化合物选自表6化合物，所述表6化合物具有如通式IV的结构且R 2和R 5如表6中所示：
表6
化合物编号 R 2 R 5
IV.1 烯丙基 CH 3
IV.2 烯丙基 CH 2CH 3
IV.3 烯丙基 CH 2CH 2CH 3
IV.4 烯丙基 CH 2CH 2CH 2CH 3
IV.5 烯丙基 CH 2CH 2CH 2CH 2CH 3
IV.6 烯丙基 CH 2CH 2CH 2CH 2CH 2CH 3
IV.7 炔丙基 CH 3
IV.8 炔丙基 CH 2CH 3
IV.9 炔丙基 CH 2CH 2CH 3
IV.10 炔丙基 CH 2CH 2CH 2CH 3
IV.11 炔丙基 CH 2CH 2CH 2CH 2CH 3
IV.12 炔丙基 CH 2CH 2CH 2CH 2CH 2CH 3
。
本发明还包括一种用于制备上述酰胺类化合物(即通式I化合物)的中间体化合物，所述中间体化合物如通式V所示：
Figure PCTCN2022104612-appb-000015
通式V中：
R 2选自烯丙基或炔丙基；
R 3选自卤素；
R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基。
在一种可能的实现方式中，通式V中，
R 2选自烯丙基或炔丙基；
R 3选自溴或碘；
R 4选自溴、碘、三氟甲基或二氟甲氧基。
在一种可能的实现方式中，中间体化合物选自表7化合物，所述表7化合物具有如通式V的结构且R 2,R 3和R 4如表7中所示：
表7
化合物编号 R 2 R 3 R 4
V.1 烯丙基 Br Br
V.2 烯丙基 Br I
V.3 烯丙基 Br CF 3
V.4 烯丙基 I CF 3
V.5 烯丙基 Br OCHF 2
V.6 烯丙基 I OCHF 2
V.7 炔丙基 Br Br
V.8 炔丙基 Br I
V.9 炔丙基 Br CF 3
V.10 炔丙基 I CF 3
V.11 炔丙基 Br OCHF 2
V.12 炔丙基 I OCHF 2
。
在一种可能的实现方式中，中间体化合物选自表8化合物，所述表8化合物具有如通式V的结构且R 2,R 3和R 4如表8中所示：
表8
化合物编号 R 2 R 3 R 4
V.3 烯丙基 Br CF 3
V.4 烯丙基 I CF 3
V.9 炔丙基 Br CF 3
V.10 炔丙基 I CF 3
。
本发明还包括一种用于制备上述酰胺类化合物(即通式I化合物)的中间体化合物，所述中间体化合物如通式VI所示：
通式VI中：
R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
R 2选自烯丙基或炔丙基；
R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基；
X选自CH或N。
在一种可能的实现方式中，通式VI中，
R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
R 2选自烯丙基或炔丙基；
R 4选自溴、碘、三氟甲基或二氟甲氧基；
X选自CH或N。
在一种可能的实现方式中，中间体化合物选自表9化合物，所述表9化合物具有如通式VI的结构且R 1,X,R 2和R 4如表9中所示：
表9
化合物编号 R 1 X R 2 R 4
VI.1 H CH 烯丙基 CF 3
VI.2 F CH 烯丙基 CF 3
VI.3 CN CH 烯丙基 CF 3
VI.4 F N 烯丙基 CF 3
VI.5 CN N 烯丙基 CF 3
VI.6 CF 3 N 烯丙基 CF 3
VI.7 H CH 炔丙基 CF 3
VI.8 F CH 炔丙基 CF 3
VI.9 CN CH 炔丙基 CF 3
VI.10 F N 炔丙基 CF 3
VI.11 CN N 炔丙基 CF 3
VI.12 CF 3 N 炔丙基 CF 3
VI.13 H CH 烯丙基 OCHF 2
VI.14 F CH 烯丙基 OCHF 2
VI.15 CN CH 烯丙基 OCHF 2
VI.16 F N 烯丙基 OCHF 2
VI.17 CN N 烯丙基 OCHF 2
VI.18 CF 3 N 烯丙基 OCHF 2
VI.19 H CH 炔丙基 OCHF 2
VI.20 F CH 炔丙基 OCHF 2
VI.21 CN CH 炔丙基 OCHF 2
VI.22 F N 炔丙基 OCHF 2
VI.23 CN N 炔丙基 OCHF 2
VI.24 CF 3 N 炔丙基 OCHF 2
。
在一种可能的实现方式中，中间体化合物选自表10化合物，所述表10化合物具有如通式VI的结构且R 1,X,R 2和R 4如表10中所示：
表10
化合物编号 R 1 X R 2 R 4
VI.1 H CH 烯丙基 CF 3
VI.2 F CH 烯丙基 CF 3
VI.3 CN CH 烯丙基 CF 3
VI.4 F N 烯丙基 CF 3
VI.5 CN N 烯丙基 CF 3
VI.6 CF 3 N 烯丙基 CF 3
VI.7 H CH 炔丙基 CF 3
VI.8 F CH 炔丙基 CF 3
VI.9 CN CH 炔丙基 CF 3
VI.10 F N 炔丙基 CF 3
VI.11 CN N 炔丙基 CF 3
VI.12 CF 3 N 炔丙基 CF 3
。
本发明还包括一种用于制备上述通式VI化合物的中间体化合物，所述中间体化合物如通式VII所示：
Figure PCTCN2022104612-appb-000016
通式VII中：
R 2选自烯丙基或炔丙基；
R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基。
在一种可能的实现方式中，通式VII中，
R 2选自烯丙基或炔丙基；
R 4选自溴、碘、三氟甲基或二氟甲氧基。
在一种可能的实现方式中，中间体化合物选自表11化合物，所述表11化合物具有如通式VII的结构且R 2和R 4如表11中所示：
表11
化合物编号 R 2 R 4
VII.1 烯丙基 CF 3
VII.2 烯丙基 OCHF 2
VII.3 炔丙基 CF 3
VII.4 炔丙基 OCHF 2
。
本发明实施例还提供了上述酰胺类化合物的制备方法，如下共五种方案(式中各基团除另有说明外定义同前，式中LG＝Cl,Br或I)：
方案一：
Figure PCTCN2022104612-appb-000017
步骤1：通式IV化合物的制备
通式VIII化合物与通式R 2-LG化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式IV化合物，反应在碱存在下进行。
步骤2：通式III化合物的制备
通式IV化合物与通式IX化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式III化合物，反应在碱或催化剂存在下进行。
步骤3：通式II化合物的制备
通式III化合物在碱存在下，在温度从-10℃到溶剂沸点下反应0.5-48小时可水解制得通式II化合物；适宜的碱可为氢氧化锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、碳酸氢钠、碳酸氢钾、溴化锂与三乙胺的混合物、溴化钠与三乙胺的混合物；适宜的溶剂可为水、甲醇、乙醇、四氢呋喃或二氧杂环己烷中的任意一种或至少两种的混合溶剂中进行。
步骤4：通式X化合物的制备
采用常规方法，通式II化合物与亚硫酰氯、草酰氯、碳酰氯、磷酰氯、五氯化磷、三氯化磷、三光气等反应，可制备得到通式X化合物。
步骤5：通式I化合物的制备
通式X化合物与通式XI化合物在适宜的溶剂中，在温度从-70℃到溶剂沸点下反应0.5-48小时可制得通式I化合物，反应在碱或催化剂存在下进行。
步骤1、步骤2及步骤5中，适宜的溶剂可为苯、甲苯、二甲苯等芳烃类，丙酮、甲乙酮、甲基异丁基酮等酮类，氯仿、二氯甲烷等卤代烃类，乙酸甲酯、乙酸乙酯等酯类，四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等醚类，水、乙腈、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等极性溶剂类或上述溶剂的混合溶剂；碱可相同或不同的为三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶、N,N-二异丙基甲胺、N,N-二异丙基乙胺等有机碱，氢化钠、氢化钾等碱金属氢化物，氢氧化钠、氢氧化钾等碱金属氢氧化物，氢氧化钙等碱土类金属氢氧化物，碳酸钠、碳酸钾等碱金属碳酸盐，碳酸氢钠等碱金属碳酸氢盐，甲醇钠、乙醇钠、乙醇钾、叔丁醇钾、叔丁醇钠等金属醇盐；催化剂可相同或不同的为碘化钾、碘化钠、氟化钾、氟化钠、溴化钾或溴化钠等。
方案二：
Figure PCTCN2022104612-appb-000018
步骤1：通式XII化合物的制备
通式XI化合物与2-氟-3-硝基苯甲酰氯在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式XII化合物，反应在碱或催化剂存在下进行。
步骤2：通式XIII化合物的制备
通式XII化合物通过还原反应制得通式XIII化合物。
作为还原反应，可以举出利用氢化反应的方法和利用金属化合物(如氯化亚锡)或金属(锌粉、铁粉等)的方法。
利用氢化反应的方法可以在适当的溶剂中，在催化剂存在下，于常压或加压下，在氢气氛围中进行反应。作为氢化反应中的催化剂，可以为钯-碳等钯催化剂、钻催化剂、铑催化剂、铂催化剂等。作为溶剂，可以为甲醇、乙醇等醇类；苯、甲苯等芳香族烃类；乙醛、四氢呋喃等链状或环状醚类；乙酸乙酯等酯类。
优选地，所述氢化反应的压力为0.1-10MPa，例如0.1MPa、0.5MPa、0.8MPa、1MPa、1.5MPa、2MPa、3MPa、4MPa、5MPa、6MPa、7MPa、8MPa、9MPa或10MPa。
优选地，所述氢化反应的温度为大于等于-20℃且小于等于反应溶剂的沸点，例如-20℃、-10℃、-5℃、0℃、5℃、10℃、15℃、20℃、25℃、30℃、35℃、40℃、45℃、50℃、60℃、70℃、75℃、80℃等，或者在溶剂沸点即回流状态下进行反应。
优选地，所述氢化反应的时间为0.5-48小时，例如0.5小时、1小时、3小时、5小时、8小时、10小时、12小时、15小时、18小时、20小时、23小时、 25小时、28小时、30小时、33小时、35小时、38小时、40小时、44小时或48小时。
优选地，所述利用金属化合物或金属的方法在甲醇、乙醇或乙酸乙酯中的任意一种或至少两种的混合溶剂中进行。
优选地，所述金属化合物为氯化亚锡，所述金属为锌粉或铁粉中的任意一种或至少两种的组合。
优选地，所述利用金属化合物或金属的方法的反应的温度为大于等于-10℃且小于等于反应溶剂的沸点，例如-10℃、-5℃、0℃、5℃、10℃、15℃、20℃、25℃、30℃、35℃、40℃、45℃、50℃、60℃、70℃、75℃、80℃等，或者在溶剂沸点即回流状态下进行反应。
优选地，所述利用金属化合物或金属的方法的反应的时间为0.5-48小时，例如0.5小时、1小时、3小时、5小时、8小时、10小时、12小时、15小时、18小时、20小时、23小时、25小时、28小时、30小时、33小时、35小时、38小时、40小时、44小时或48小时。
步骤3：通式V化合物的制备
通式XIII化合物与通式R 2-LG化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式V化合物，反应在碱或催化剂存在下进行。
步骤4：通式I化合物的制备
通式V化合物与通式IX化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I化合物，反应在碱或催化剂存在下进行。
步骤1、步骤3及步骤4中，适宜的溶剂可相同或不同的为苯、甲苯、二甲苯等芳烃类，丙酮、甲乙酮、甲基异丁基酮等酮类，氯仿、二氯甲烷等卤代烃类，乙酸甲酯、乙酸乙酯等酯类，四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等醚类，水、乙腈、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等极性溶剂类或上述溶剂的混合溶剂；碱可相同或不同的为三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶、N,N-二异丙基甲胺、N,N-二异丙基乙胺等有机碱，氢化钠、氢化钾等碱金属氢化物，氢氧化钠、氢氧化钾等碱金属氢氧化物，氢氧化钙等碱土类金属氢氧化物，碳酸钠、碳酸钾等碱金属碳酸盐，碳酸氢钠等碱金属碳酸氢盐，甲醇钠、乙醇钠、乙醇钾、叔丁醇钾、叔丁醇钠等金属醇盐；催化剂可 相同或不同的为碘化钾、碘化钠、氟化钾、氟化钠、溴化钾或溴化钠等。
方案三：
Figure PCTCN2022104612-appb-000019
步骤1：通式VI化合物的制备
通式X化合物与通式XIV化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式VI化合物；反应可加入适量的碱或催化剂以帮助反应能够更好地进行。适宜的溶剂可为苯、甲苯、二甲苯等芳烃类，丙酮、甲乙酮、甲基异丁基酮等酮类，氯仿、二氯甲烷等卤代烃类，乙酸甲酯、乙酸乙酯等酯类，四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等醚类，水、乙腈、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等极性溶剂类或上述溶剂的混合溶剂；碱可相同或不同的为三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶、N,N-二异丙基甲胺、N,N-二异丙基乙胺等有机碱，氢化钠、氢化钾等碱金属氢化物，氢氧化钠、氢氧化钾等碱金属氢氧化物，氢氧化钙等碱土类金属氢氧化物，碳酸钠、碳酸钾等碱金属碳酸盐，碳酸氢钠等碱金属碳酸氢盐，甲醇钠、乙醇钠、乙醇钾、叔丁醇钾、叔丁醇钠等金属醇盐；催化剂可相同或不同的为碘化钾、碘化钠、氟化钾、氟化钠、溴化钾或溴化钠等。
步骤2：通式I化合物的制备
通式VI化合物与适宜的卤代试剂在适宜的溶剂中反应可制得通式I化合物。
反应通常需要适宜的碱参与，适宜的碱可选自三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶、N,N-二异丙基甲胺、N,N-二异丙基乙胺、氢化钠、氢化钾、氢氧化钠、氢氧化钾、氢氧化钙、碳酸钠、碳酸钾、碳酸氢钠、碳酸氢钾、甲醇钠、乙醇钠、乙醇钾、叔丁醇钾或叔丁醇钠；优选氢化钠、氢化钾、氢氧化钠或氢氧化钾。
适宜的卤代试剂选自氯气、液溴、碘、NBS、NCS、NIS、双氧水与氢溴酸的混合物、双氧水与氢碘酸的混合物、次氯酸钠与氢溴酸的混合物、次氯酸钠与氢碘酸的混合物、氯酸钠与氢溴酸的混合物或氯酸钠与氢碘酸的混合物。
适宜的溶剂选自苯、甲苯、二甲苯、丙酮、甲乙酮、甲基异丁基酮、氯 仿、二氯甲烷，乙酸甲酯、乙酸乙酯、四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷、水、乙腈、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二甲基亚砜或上述溶剂的混合溶剂。
反应温度为-10℃到所选溶剂沸点；优选反应温度0℃-100℃，更优选25℃-80℃。
反应时间为0.5-48小时，优选1-10小时。
方案四：
Figure PCTCN2022104612-appb-000020
步骤1：通式XV化合物的制备
通式XIV化合物与2-氟-3-硝基苯甲酰氯在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式XV化合物，反应在碱或催化剂存在下进行。
步骤2：通式XVI化合物的制备
通式XV化合物通过还原反应制可得通式XVI化合物。
作为还原反应，可以举出利用氢化反应的方法和利用金属化合物(如氯化亚锡)或金属(锌粉、铁粉等)的方法。
利用氢化反应的方法可以在适当的溶剂中，在催化剂存在下，于常压或加压下，在氢气氛围中进行反应。作为氢化反应中的催化剂，可以为钯-碳等钯催化剂、钻催化剂、铑催化剂、铂催化剂等。作为溶剂，可以为甲醇、乙醇等醇类；苯、甲苯等芳香族烃类；乙醛、四氢呋喃等链状或环状醚类；乙酸乙酯等酯类。
优选地，所述氢化反应的压力为0.1-10MPa，例如0.1MPa、0.5MPa、0.8MPa、1MPa、1.5MPa、2MPa、3MPa、4MPa、5MPa、6MPa、7MPa、8MPa、9MPa或10MPa。
优选地，所述氢化反应的温度为大于等于-20℃且小于等于反应溶剂的沸点，例如-20℃、-10℃、-5℃、0℃、5℃、10℃、15℃、20℃、25℃、30℃、35℃、40℃、45℃、50℃、60℃、70℃、75℃、80℃等，或者在溶剂沸点即回流状态下进行反应。
优选地，所述氢化反应的时间为0.5-48小时，例如0.5小时、1小时、3小时、5小时、8小时、10小时、12小时、15小时、18小时、20小时、23小时、25小时、28小时、30小时、33小时、35小时、38小时、40小时、44小时或48小时。
优选地，所述利用金属化合物或金属的方法在甲醇、乙醇或乙酸乙酯中的任意一种或至少两种的混合溶剂中进行。
优选地，所述金属化合物为氯化亚锡，所述金属为锌粉或铁粉中的任意一种或至少两种的组合。
优选地，所述利用金属化合物或金属的方法的反应的温度为大于等于-10℃且小于等于反应溶剂的沸点，例如-10℃、-5℃、0℃、5℃、10℃、15℃、20℃、25℃、30℃、35℃、40℃、45℃、50℃、60℃、70℃、75℃、80℃等，或者在溶剂沸点即回流状态下进行反应。
优选地，所述利用金属化合物或金属的方法的反应的时间为0.5-48小时，
例如0.5小时、1小时、3小时、5小时、8小时、10小时、12小时、15小时、18小时、20小时、23小时、25小时、28小时、30小时、33小时、35小时、38小时、40小时、44小时或48小时。
步骤3：通式VII化合物的制备
通式XVI化合物与通式R 2-LG化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式VII化合物，反应在碱或催化剂存在下进行。
步骤4：通式VI化合物的制备
通式VII化合物与通式IX化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式VI化合物，反应在碱或催化剂存在下进行。
步骤5：通式I化合物的制备
同方案三的步骤2。
步骤1、步骤3及步骤4中，适宜的溶剂可相同或不同的为苯、甲苯、二 甲苯等芳烃类，丙酮、甲乙酮、甲基异丁基酮等酮类，氯仿、二氯甲烷等卤代烃类，乙酸甲酯、乙酸乙酯等酯类，四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等醚类，水、乙腈、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等极性溶剂类或上述溶剂的混合溶剂；碱可相同或不同的为三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶、N,N-二异丙基甲胺、N,N-二异丙基乙胺等有机碱，氢化钠、氢化钾等碱金属氢化物，氢氧化钠、氢氧化钾等碱金属氢氧化物，氢氧化钙等碱土类金属氢氧化物，碳酸钠、碳酸钾等碱金属碳酸盐，碳酸氢钠等碱金属碳酸氢盐，甲醇钠、乙醇钠、乙醇钾、叔丁醇钾、叔丁醇钠等金属醇盐；催化剂可相同或不同的为碘化钾、碘化钠、氟化钾、氟化钠、溴化钾或溴化钠等。
方案五：
Figure PCTCN2022104612-appb-000021
步骤1：通式XVII化合物的制备
通式VIII化合物与通式IX化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式XVII化合物，反应在碱或催化剂存在下进行。
步骤2：通式III化合物的制备
通式XVII化合物与通式R 2-LG化合物在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式III化合物，反应在碱或催化剂存在下进行。
步骤3：通式II化合物的制备
同方案一的步骤3。
步骤4：通式X化合物的制备
同方案一的步骤4。
步骤5：通式I化合物的制备
同方案一的步骤5。
步骤1和步骤2中，适宜的溶剂可相同或不同的为苯、甲苯、二甲苯等芳烃类，丙酮、甲乙酮、甲基异丁基酮等酮类，氯仿、二氯甲烷等卤代烃类，乙酸甲酯、乙酸乙酯等酯类，四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等醚类，水、乙腈、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等极性溶剂类或上述溶剂的混合溶剂；碱可相同或不同的为三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶、N,N-二异丙基甲胺、N,N-二异丙基乙胺等有机碱，氢化钠、氢化钾等碱金属氢化物，氢氧化钠、氢氧化钾等碱金属氢氧化物，氢氧化钙等碱土类金属氢氧化物，碳酸钠、碳酸钾等碱金属碳酸盐，碳酸氢钠等碱金属碳酸氢盐，甲醇钠、乙醇钠、乙醇钾、叔丁醇钾、叔丁醇钠等金属醇盐；催化剂可相同或不同的为碘化钾、碘化钠、氟化钾、氟化钠、溴化钾或溴化钠等。
通式XI化合物、通式XIV化合物可以按公知方法制备，例如参照WO20110201687、WO2011093415、WO2005021488、WO2005073165、WO2006137395、JP2007099761、WO2008000438、WO2008074427、WO2008107091、WO2010013567、WO2010018714、WO2010090282、WO2010127926、WO2010127928、JP2011063549、WO2012020483、WO2012020484、WO2012077221、WO2012164698、WO2013050261、WO2014069665、WO2014067838、WO2014161848、WO2014161850、WO2015097091或WO2015097094等报道的方法制得；通式VIII化合物、通式IX化合物及通式R 2-LG化合物通常有市售，也可按照常规方法自制。
本发明实施例还提供了上述酰胺类化合物在制备杀虫剂中的用途。
在一种可能的实现方式中，所述杀虫剂用于防治以下昆虫的一种或多种：甲虫(鞘翅目昆虫(Coleopteran))，例如绿豆象(Callosobruchus Chinensis)、玉米象(Sitophilus zeamais)、赤拟谷盗(Tribolium Castaneum)、马铃薯瓢虫(Epilachna vigintioctomaculata)、细胸叩甲(Agriotes ogurae fuscicollis)、多色异丽金龟(Anomala rufocuprea)、马铃薯叶甲(Leptinotarsa decemlineata)、叶甲属(Diabrotica spp.)、松墨天牛(Monochamus alternatus endai)、稻根象(Lissorhoptrus oryzophilus)、褐粉蠹(Lyctus bruneus)；
鳞翅目(lepidopteran)害虫，例如，舞毒蛾(Lymantria dispar)、黄褐天幕毛虫(Malacosoma neustria)、菜粉蝶日本亚种(Pieris rapae crucivora)、斜纹夜蛾 (Spodoptera litura)、甘蓝夜蛾(Mamestra brassicae)、二化螟(Chilo suppressalis)、欧洲玉米螟(Ostrinia nubilalis)、干果斑螟(Cadra cautella)、chyanokokakumonhamaki(Adoxophyes honmai)、苹果小卷蛾(Cydia pomonella)、黄地老虎(Agrotis segetum)、大蜡螟(Galleria mellonella)、菜蛾(Plutella xylostella)、烟芽夜蛾(Heliothis virescens)、桔潜蛾(Phyllocnistis citrella)；
半翅目(Hemipterous)害虫，例如，黑尾叶蝉(Nephotettix cincticeps)、褐飞虱(Nilaparvata lugens)、康氏粉蚧(Pseudococcus comstocki)、矢尖盾蚧(Unaspis yanonensis)、桃蚜(Myzus persicas)、苹果蚜(Aphis pomi)、棉蚜(Aphis gossypii)、萝卜蚜(Lipaphis erysimi)、梨冠网蝽(Stephanitis nashi)、绿椿属(Nezara spp.)、温室粉虱(Trialeurodes vaporariorum)、Pshylla spp.；
缨翅目(Thysanoptera)害虫，例如棕榈蓟马(Thrips palmi)、西方花蓟马(Franklinella occidentalis)；
直翅目(orthopteran)害虫，例如非洲蝼蛄(Gryllotalpa Africana)、非洲飞蝗(Locusta migratoria)；
蜚蠊目(blattarian)害虫，例如德国蠊(Blattella germanica)、美洲大蠊(Periplaneta americana)、黄胸散白蚁(Reticulitermes speratus)、家白蚁(Coptotermes formosanus)；
双翅目(Dipterous)害虫，例如家蝇(Musca domestica)、埃及伊蚊(Aedesaegypti)、灰地种蝇(Delia platura)、淡色库蚊(Culex pipiens pallens)、中华按蚊(Anopheles sinensis)、三带喙库蚊(Culex tritaeniorhynchus)、三叶草斑潜蝇(Liriomyza trifolii)等。
农业害螨，如朱砂叶螨(Tetranychus cinnabarinus)、棉叶螨(Tetrahychus urticae)、桔全爪螨(Panonychus citri)、桔刺皮瘿螨(Aculops pelekassi)、跗线螨属(Tarsonemus spp.)等。
在一种可能的实现方式中，所述杀虫剂用于防治小菜蛾、粘虫、甜菜夜蛾、斜纹夜蛾、二化螟、桃蚜、蓟马、跳甲中的一种或几种。
本发明实施例还提供了一种杀虫剂制剂，该杀虫剂制剂中含有上述酰胺类化合物作为活性组分，还含有一种或多种辅料。
在一种可能的实现方式中，杀虫剂制剂选自以下剂型：溶液剂、乳剂、 可湿性粉剂、颗粒状可湿性粉剂、悬浮剂、粉剂(powder)、泡沫剂、膏剂、片剂、颗粒剂、气雾剂、经活性化合物浸渍的天然试剂、经活性化合物浸渍的合成试剂、微胶囊剂、种子包衣剂、装备有燃烧装置的制剂(所述燃烧装置可为烟筒和雾筒、罐和盘管等)以及ULV(冷雾剂、热雾剂)等。这些杀虫剂制剂或动物寄生虫防治剂可用已知的方法制备，例如可通过将活性组分与填充剂(如：液体稀释剂或载体、液化气稀释剂或载体、固体稀释剂或载体)混合，以及可选地与表面活性剂(即乳化剂和/或分散剂和/或发泡剂)等混合而制备。
在一种可能的实现方式中，所述辅料包括以下的一种或多种：填充剂(如：液体稀释剂或载体、液化气稀释剂或载体、固体稀释剂或载体)、表面活性剂(如：乳化剂和/或分散剂和/或发泡剂)、粘合剂、着色剂；
液体稀释剂或载体可包括，例如，芳香烃(二甲苯、甲苯、烷基萘等)、氯代芳烃或氯代脂族烃(例如氯苯、氯乙烯、二氯甲烷等)、脂族烃(例如环己烷或石蜡(例如矿物油馏分))、醇(例如丁醇、乙二醇，及其醚或酯等)、酮(例如丙酮、甲基乙基酮、甲基异丁基酮、环己酮等)、强极性溶剂(例如二甲基甲酰胺、二甲亚砜)、水等。当使用水作为填充剂时，例如，可使用有机溶剂作为助溶剂；
液化气稀释剂或载体可包括在大气压力和温度下以气体形式存在的那些，例如，丙烷、氮气、二氧化碳，以及气溶胶喷射剂例如卤代烃；
固体稀释剂可包括粉碎的天然矿物(例如高岭土、粘土、滑石、白垩、石英、绿坡缕石、蒙脱石或硅藻土等)以及粉碎的合成矿物(例如细分散的硅酸、氧化铝和硅酸盐等)等；
乳化剂和/或发泡剂可包括非离子及阴离子乳化剂[例如，聚氧乙烯脂肪酸酯、聚氧乙烯脂肪酸醇醚(如烷基芳基聚乙二醇醚)、烷基磺酸盐、烷基硫酸盐和芳基磺酸盐]以及白蛋白水解产物等；
分散剂可包括木质素亚硫酸盐废液和甲基纤维素；
粘合剂可包括羧甲基纤维素、天然或合成的聚合物(例如阿拉伯树胶、聚乙烯醇和聚乙酸乙烯酯等)；
着色剂可包括无机颜料(例如氧化铁、氧化钛和普鲁士蓝等)、有机染料例如茜素染料、偶氮染料或金属酞菁染料；及微量元素，例如铁盐、锰盐、硼盐、铜盐、钴盐、钼盐或锌盐。
此外，本发明的酰胺类化合物可作为与一种增效剂的混合物存在，增效剂自身不必具有活性。更确切地，它是增强活性化合物活性的化合物。
在一种可能的实现方式中，杀虫剂制剂中含有的上述酰胺类化合物的量为0.1至99重量％，可选地为0.5至90重量％。
本发明实施例还提供了一种杀虫剂组合物，其包括上述酰胺类化合物和其他活性化合物(例如杀虫剂、毒饵剂、消毒剂、杀螨剂、杀线虫剂、杀真菌剂、生长调节剂、除草剂等)的混合物。该混合物可以以原料药的形式提供，也可以以市售有用制剂的形式或者由其制剂制得的使用形式提供。
本发明实施例还提供了一种控制农业或林业害虫的方法，其包括以下步骤：将有效剂量的材料施用于需要控制的害虫或其生长介质上，所述材料选自下组中的一种或多种：上述酰胺类化合物、上述杀虫剂制剂、上述杀虫剂组合物。
本发明实施例还提供了上述酰胺类化合物在制备动物寄生虫防治剂中的用途。在兽医领域内，即，兽医科学中，本发明酰胺类化合物可以有效地用于对抗多种有害的动物类寄生虫，特别是体内寄生虫和体外寄生虫。
在一种可能的实现方式中，动物寄生虫包括以下的一种或多种：
虱目(Anoplurida)，例如血虱属(Haematopinus spp.)、毛虱属(Linognathus spp.)、虱属(Pediculus spp.)、Phtirus spp和管虱属(Solenopotes spp.)；特别地，代表性实例有，棘颚虱(Linognathus setosus)、牛管虱(Solenopotes capillatus)；
食毛目(Mallopha、牛颚虱(Linognathus vituli)、绵羊颚虱(Linognathus ovillus)、Linognathus oviformis、足颚虱(Linognathus pedalis)、山羊颚虱(Linognathus stenopsis)、驴血虱(Haematopinus asini macrocephalus)、牛血虱(Haematopinus eurysternus)、猪血虱(Haematopinus suis)、头虱(Pediculus humanus capitis)、体虱(Pediculus humanus corporis)、葡萄根瘤蚜(Phylloera vastatrix)、阴虱(Phthirus pubis)gida)和钝角亚目(Amblycerina)和细角亚目(Ischnocerin)，例如，毛羽虱属(Trimenopon spp.)、禽虱属(Menopon spp.)、巨羽虱属(Trinoton spp.)、牛羽虱属(Bovicola spp.)、Werneckiella spp.、Lepikentron spp.、畜虱属(Damalina spp.)、嚼虱属(Trichodectes spp.)和猫羽虱属(Felicola spp.)；特别地，代表性实例有，牛毛虱(Bovicola bovis)、羊毛虱(Bovicola ovis)、安哥拉山羊羽虱(Bovicola limbata)、牛畜虱(Damalina bovis)、犬毛虱(Trichodectes canis)、猫羽虱(Felicola subrostratus)、 山羊毛虱(Bovicola caprae)、Lepikentron ovis、咬虱(Werneckiella equi)；
双翅目(Diptera)及其长角亚目(Nematocerina)和短角亚目(Brachycerina)，例如，伊蚊属(Aedes spp.)、按蚊属(Anopheles spp.)、库蚊属(Culex spp.)、蚋属(Simulium spp)、真蚋属(Eusimulium spp.)、白蛉属(Phlebotomus spp.)、罗蛉属(Lutzomyia spp.)、库蠓属(Culicoides spp.)、斑虻属(Chrysops spp.)、短蚋属(Odagmia spp.)、维蚋属(Wilhelmia spp.)、瘤虻属(Hybomitra spp.)、黄虻属(Atylotus spp.)、虻属(Tabanus spp.)、麻虻属(Haematopota spp.)、Philipomyia spp.、蜂虱蝇属(Braula spp.)、家蝇属(Musca spp.)、齿股蝇属(Hydrotaea spp.)、螫蝇属(Stomoxys spp.)、黑角蝇属(Haematobia spp.)、莫蝇属(Morellia spp.)、厕蝇属(Fannia spp.)、舌蝇属(Glossina spp.)、丽蝇属(Calliphora spp.)、绿蝇属(Lucilia spp.)、金蝇属(Chrysomyia spp.)、污蝇属(Wohlfahrtia spp.)、麻蝇属(Sarcophaga spp.)、狂蝇属(Oestrus spp.)、皮蝇属(Hypoderma spp.)、胃蝇属(Gasterophilus spp.)、虱蝇属(Hippobosca spp.)、羊虱蝇属(Lipoptena spp.)、蜱蝇属(Melophagus spp.)、鼻狂蝇属(Rhinoestrus spp.)、大蚊属(Tipula spp.)；特别地，代表性实例有，埃及伊蚊(Aedes aegypti)、白纹伊蚊(Aedes albopictus)、带喙伊蚊(Aedes taeniorhynchus)、冈比亚按蚊(Anopheles gambiae)、五斑按蚊(Anopheles maculipennis)、红头丽蝇(Calliphora erythrocephala)、高额麻虻(Chrysozona pluvialis)、五带淡色库蚊(Culex quinquefasciatus)、尖音库蚊(Culex pipiens)、环喙库蚊(Culex tarsalis)、夏厕蝇(Fannia canicularis)、肉蝇(Sarcophaga carnaria)、厩螯蝇(Stomoxys calcitrans)、欧洲大蚊(Tipula paludosa)、铜绿蝇(Lucilia cuprina)、丝光绿蝇(Lucilia sericata)、爬蚋(Simulium reptans)、静食白蛉(Phlebotomus papatasi)、长须白蛉(Phlebotomus longipalpis)、华丽短蚋(Odagmia ornata)、马维蚋(Wilhelmia equina)、红头厌蚋(Boophthora erythrocephala)、多声虻(Tabanus bromius)、夜蛾虻(Tabanus spodopterus)、北美黑虻(Tabanus atratus)、猪虻(Tabanus sudeticus)、古氏瘤虻(Hybomitra ciurea)、盲斑虻(Chrysops caecutiens)、黄缘斑虻(Chrysops relictus)、高额麻虻(Haematopota pluvialis)、Haematopotaitalica、秋家蝇(Musca autumnalis)、家蝇(Musca domestica)、西方角蝇(Haematobia irritans irritans)、西方角蝇(Haematobia irritans exigua)、刺扰血蝇(Haematobia stimulans)、Hydrotaea irritans、白斑齿股蝇(Hydrotaea albipuncta)、Chrysomya chloropyga、蛆症金蝇(Chrysomya bezziana)、羊狂蝇(Oestrus ovis)、牛皮蝇(Hypoderma bovis)、 纹皮蝇(Hypoderma lineatum)、Przhevalskiana silenus、人肤蝇(Dermatobia hominis)、羊蜱蝇(Melophagus ovinus)、Lipoptena capreoli、鹿羊虱蝇(Lipoptena cervi)、Hippobosca variegata、马虱蝇(Hippobosca equina)、肠胃蝇(Gasterophilus intestinalis)、赤尾胃蝇(Gasterophilus haemorroidalis)、裸节胃蝇(Gasterophilus interrnis)、鼻胃蝇(Gasterophilus nasalis)、黑角胃蝇(Gasterophilus nigricornis)、黑腹胃蝇(Gasterophilus pecorum)、蜂虱蝇(Braula coeca)；
蚤目(Siphonapterida)，例如，蚤属(Pulex spp.)、栉首蚤属(Ctenocephalides spp.)、潜蚤属(Tunga spp.)、客蚤属(Xenopsylla spp.)、角叶蚤属(Ceratophyllus spp.)；特别地，代表性实例有，犬栉首蚤(Ctenocephalides canis)、猫栉首蚤(Ctenocephalides felis)、人蚤(Pulex irritans)、穿皮潜蚤(Tunga penetrans)、印鼠客蚤(Xenopsylla cheopis)；
异翅目(Heteropterida)，例如，臭虫属(Cimex spp.)、锥猎椿属(Triatoma spp.)、红猎蝽属(Rhodnius spp.)、锥蝽属(Panstrongylus spp.)；
蜚蠊目(Blattarida)，例如，东方蜚蠊(Blatta orientalis)、美洲大蠊、德国蠊、夏柏拉蟑螂属(Supella spp.)(例如，Suppella longipalpa)；
蜱螨目(Acari)(或Acarina)，后气门目(Metastigmata)和中气门目(Mesostigmata)，例如，锐缘蜱属(Argas spp.)、钝缘蜱属(Ornithodorus spp.)、残喙蜱属(Otobius spp.)、硬蜱属(Ixodes spp.)、花蜱属(Amblyomma spp.)、牛蜱属(Rhipicephalus(Boophilus)spp.)、革蜱属(Dermacentor spp.)、Haemophysalis spp.、璃眼蜱属(Hyalomma spp.)、皮刺螨属(Dermanyssus spp.)、扇头蜱属(Rhipicephalus spp.)(异主寄生型螨的原属)、禽刺螨属(Ornithonyssus spp.)、肺刺螨属(Pneumonyssus spp.)、Pneumonyssus spp.、刺利螨属(Raillietia spp.)、肺刺螨属(Pneumonyssus spp.)、胸刺螨属(Sternostoma spp.)、蜂螨属(Varroa spp.)、蜂盾螨属(Acarapis spp.)；特别地，代表性实例有，波斯锐缘蜱(Argas persicus)、鸽锐缘蜱(Argas reflexus)、非洲钝缘蜱(Ornithodorus moubata)、耳残喙蜱(Otobius megnini)、微小扇头蜱(微小牛蜱)(Rhipicephalus(Boophilus)microplus)、消色扇头蜱(消色牛蜱)(Rhipicephalus(Boophilus)decoloratus)、具环扇头蜱(具环牛蜱)(Rhipicephalus(Boophilus)annulatus)、有矩扇头蜱(有矩牛蜱)(Rhipicephalus(Boophilus)calceratus)、Hyalomma anatolicum、埃及璃眼蜱 (Hyalommaaegypticum)、Hyalomma marginatum、Hyalomma transiens、外翻扇头蜱(Rhipicephalusevertsi)、蓖子硬蜱(Ixodes ricinus)、六角硬蜱(Ixodes hexagonus)、原野硬蜱(Ixodes canisuga)、多毛硬蜱(Ixodes pilosus)、浅红硬蜱(Ixodes rubicundus)、肩突硬蜱(Ixodes scapularis)、全环硬蜱(Ixodes holocyclus)、嗜群血蜱(Haemaphysalis concinna)、刻点血蜱(Haemaphysalis punctata)、Haemaphysalis cinnabarina、Haemaphysalis otophila、犬血蜱(Haemaphysalis leachi)、长角血蜱(Haemaphysalis longicorni)、边缘革蜱(Dermacentor marginatus)、网纹革蜱(Dermacentor reticulatus)、Dermacentor pictus、白纹革蜱(Dermacentor albipictus)、安氏革蜱(Dermacentor andersoni)、变异革蜱(Dermacentor variabilis)、毛里求斯璃眼蜱(Hyalomma mauritanicum)、血红扇头蜱(Rhipicephalus sanguineus)、囊形扇头蜱(Rhipicephalus bursa)、非洲扇头蜱(Rhipicephalus appendiculatus)、好望角扇头蜱(Rhipicephalus capensis)、图兰扇头蜱(Rhipicephalus turanicus)、Rhipicephalus zambeziensis、美洲花蜱(Amblyomma americanum)、彩饰花蜱(Amblyomma variegatum、有斑花蜱(Amblyomma maculatum)、希伯来花蜱(Amblyomma hebraeum)、卡延花蜱(Amblyomma cajennense)、鸡皮刺螨(Dermanyssus gallinae)、囊禽刺螨(Ornithonyssus bursa)、林禽刺螨(Ornithonyssus sylviarum)、大蜂螨(Varroa jacobsconi)；
轴螨目(Actinedida)(前气门亚目(Prostigmata))和粉螨目(Acaridida)(无气门亚目(Astigmata))，例如，蜂盾螨属(Acarapis spp.)、姬螯螨属(Cheyletiella spp.)、禽螯螨属(Ornithocheyletia spp.)、肉螨属(Myobia spp.)、疮螨属(Psorergates spp.)、蠕形螨属(Demodex spp.)、恙螨属(Trombicula spp.)、Listrophorus spp.、粉螨属(Acarus spp.)、食酪螨属(Tyrophagus spp.)、嗜木螨属(Caloglyphus spp.)、颈下螨属(Hypodectes spp.)、翅螨属(Pterolichus spp.)、痒螨属(Psoroptes spp.)、皮螨属(Chorioptes spp.)、耳疥螨属(Otodectes spp.)、疥螨属(Sarcoptes spp.)、耳螨属(Notoedres spp.)、疙螨属(Knemidocoptes spp.)、气囊螨属(Cytodites spp.)和鸡雏螨属(Laminosioptes spp.)；特别是，雅氏姬螯螨(C heyletiella yasguri)、布氏姬螯螨(C heyletiella blakei)、犬蠕形螨(Demodex canis)、牛蠕形螨(Demodex bovis)、绵羊蠕形螨(Demodex ovis)、山羊蠕形螨(Demodex caprae)、马蠕形螨(Demodex equi)、Demodex caballi、猪蠕形螨(Demodex suis)、Neotrombicula autumnalis、 Neotrombiculadesaleli、Neoschonegastia xerothermobia、秋收恙螨(Trombicula akamushi)、狗耳螨(Otodectes cynotis)、猫痂螨(Notoedres cati)、狗疥螨(Sarcoptis canis)、牛疥螨(Sarcoptes bovis)、绵羊疥螨(Sarcoptes ovis)、山羊疥螨(Sarcoptes rupicaprae(＝S.caprae))、马疥螨(Sarcoptes equi)、猪疥螨(Sarcoptes suis)、绵羊瘙螨(Psoroptes ovis)、兔瘙螨(Psoroptes cuniculi)、马瘙螨(Psoroptes equi)、牛痒螨(Chorioptes bovis)、Psoergates ovis、Pneumonyssoidic mange、犬鼻疥蟲(Pneumonyssoides caninum)、伍氏蜂跗线螨(Acarapis woodi)；
线虫，例如南方根结线虫(Meloidogyne incognita)、松材线虫(Bursaphelenchus xylophilus)、水稻干尖线虫(Aphelenchoides besseyi)、大豆异皮线虫(Heterodera glycines)、短体线虫属(Pratylenchus spp.)等。
侵袭动物的节肢动物、蠕虫和疟原虫。防治节肢动物、蠕虫和/或疟原虫，可减少家养动物的死亡率，并且可改善动物的生产率(肉、奶、毛、皮、蛋和蜜)和健康。
在一种可能的实现方式中，所述动物寄生虫防治剂用于防治猫蚤、美洲犬蜱中的一种或几种。
在一种可能的实现方式中，动物包括以下的一种或多种：农业动物，例如牛、绵羊、山羊、马、猪、驴、骆驼、水牛、兔、家鸡、火鸡、鸭、鹅、养殖鱼、蜜蜂等；也包括被称为伴侣动物的宠物，例如，狗、猫、笼鸟、观赏鱼；还包括用于实验的动物，例如仓鼠、豚鼠、大鼠和小鼠等。
本发明实施例还提供了一种动物寄生虫防治剂，该动物寄生虫防治剂中含有上述酰胺类化合物作为活性组分，还含有一种或多种辅料。
在一种可能的实现方式中，动物寄生虫防治剂选自以下剂型：片剂、胶囊剂、饮剂、可饮用药、颗粒剂、膏剂和丸剂、栓剂、注射剂(肌肉、皮下、静脉内、腹膜内等)、涂抹剂、气雾剂、无压喷雾剂(例如泵喷雾剂和雾化喷雾剂)。
在一种可能的实现方式中，动物寄生虫防治剂中含有的上述活性组分的量为1至80重量％的量。
本发明实施例还提供了一种动物寄生虫防治组合物，其包括上述酰胺类化合物和其他动物寄生虫防治活性化合物(例如杀螨剂、杀昆虫剂、杀寄生虫剂、抗疟原虫剂等)的混合物。该混合物可以以原料药的形式提供，也可以以市售有 用制剂的形式或者由其制剂制得的使用形式提供。
本发明实施例还提供了一种控制动物寄生虫的方法，其包括以下步骤：将有效剂量的材料施于需要控制的动物寄生虫或其生长介质上，所述材料选自下组中的一种或多种：上述酰胺类化合物；上述动物寄生虫防治剂；上述动物寄生虫防治组合物。例如：采用片剂、胶囊剂、饮剂、可饮用药、颗粒剂、膏剂、丸剂、栓剂进行肠内给药；基于皮肤施用的非肠内给药，例如注射(肌肉、皮下、静脉内、腹膜内等)、植入、鼻部给药，包括洗浴或浸泡、喷雾、泼浇、点滴、清洗和撒粉，和通过使用含有活性化合物的模型制品，例如项圈、耳标、标签、腿部缚带(leg brace)、网、标识器等施用。本发明的活性化合物具有低毒性，可以安全地用于温血动物。
有益效果
本发明的酰胺类化合物具有意想不到的优异的杀虫效果，其也对有毒的害虫展现出合适的防治效果，且对栽培的作物植物没有植物毒性。此外，本发明的化合物可用于防治多种害虫，例如有害的刺吸式昆虫、咀嚼式昆虫以及其他植物寄生害虫、储存谷物害虫、卫生害虫等，并且可用于消毒和杀灭它们。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚，下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
另外，为了更好的说明本发明，在下文的具体实施方式中给出了众多的具体细节。本领域技术人员应当理解，没有某些具体细节，本发明同样可以实施。在一些实施例中，对于本领域技术人员熟知的原料、元件、方法、手段等未作详细描述，以便于凸显本发明的主旨。
除非另有其它明确表示，否则在整个说明书和权利要求书中，术语“包括”或其变换如“包含”或“包括有”等等将被理解为包括所陈述的元件或组成部分，而并未排除其它元件或其它组成部分。
除另有注明外，所用原料均有市售。
本发明中，所用术语具有如下含义：
卤素：指氟、氯、溴或碘。
卤代烷基：直链或支链烷基，在这些烷基上的氢原子可以部分或全部被卤素所取代，例如二氟甲基(CHF 2)、三氟甲基(CF 3)等。
卤代烷氧基：烷氧基上的氢原子可部分或全部被卤素所取代，例如二氟甲氧基(OCHF 2)、三氟甲氧基(OCF 3)等。
烯丙基：-CH 2-CH＝CH 2。
炔丙基：-CH 2-C≡CH。
杀虫剂：对害虫具有杀虫效果的物质。
动物寄生虫防治剂：是指能有效地将被寄生虫感染的动物中的各种寄生虫的发病率减少的活性化合物。防治意味着活性化合物能有效地杀灭寄生虫、抑制其生长或繁殖。
合成实施例
按照上述记载的合成路线，采用不同的原料化合物，即可分别制备获得本发明通式I～VII所示化合物，进一步具体描述如下：
实施例1：中间体化合物II.7的制备
Figure PCTCN2022104612-appb-000022
(1)2-氟-3-(N-(丙-2-炔-1-基)苯甲酰氨基)苯甲酸酯(III.7)的制备
向10毫升甲苯中加入0.50克(2.96毫摩尔)2-氟-3-氨基苯甲酸甲酯、0.70克(5.94毫摩尔)溴丙炔、1.15克(8.90毫摩尔)N,N-二异丙基乙胺，升温回流反应。TLC监测反应进程，待原料反应完全后，加入0.58克(4.14毫摩尔)苯甲酰氯，TLC监测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.72克，即2-氟-3-(N-(丙-2-炔-1-基)苯甲酰氨基)苯甲酸甲酯(III.7)；中间 体III.7的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ7.82(t,1H),7.42–7.13(m,6H),7.07(t,1H),5.05(s,1H),4.28(s,1H),3.91(s,3H),2.23(t,1H)。LC-MS(m/z,ESI):312.10(M+H) +。
(2)2-氟-3-(N-(丙-2-炔-1-基)苯甲酰氨基)苯甲酸(II.7)的制备
向10毫升乙腈中加入0.58克(1.86毫摩尔)2-氟-3-(N-(丙-2-炔-1-基)苯甲酰氨基)苯甲酸甲酯、1.62克(18.65毫摩尔)溴化锂、0.94克(9.29毫摩尔)三乙胺、0.17克(9.44毫摩尔)水，升温至50度反应。TLC监测反应完毕后，用稀盐酸调pH值至2-3左右，加入水和乙酸乙酯萃取，有机相减压脱溶，得白色固体0.52克，即中间体II.7。中间体II.7的核磁及质谱数据如下：
1H NMR(600MHz,DMSO-d 6)δ7.79–7.64(m,2H),7.42–7.17(m,6H),4.61(s,2H),3.22(s,1H)。LC-MS(m/z,ESI):296.11(M-H) -。
实施例2：中间体化合物V.3的制备
Figure PCTCN2022104612-appb-000023
向10毫升DMF中加入1.00克(1.84毫摩尔)3-氨基-N-(2-溴-4-(全氟丙-2-基)-6-(三氟甲基)苯基)-2-氟苯甲酰胺(参照WO2011093415或WO2010018714报道的方法制得)及0.30克(2.00毫摩尔)碘化钠，搅拌下滴加0.22克(1.83毫摩尔)溴丙烯，室温反应。TLC检测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.34克，即中间体化合物V.3。中间体化合物V.3的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.26(d,1H),8.14(d,1H),7.91(d,1H),7.42–7.36(m,1H),7.14(t,1H),6.95–6.87(m,1H),6.03–5.91(m,1H),5.34(dd,1H),5.24(dd,1H),4.26(s,1H),3.87(d,2H)。LC-MS(m/z,ESI):585.08(M+H) +。
实施例3：中间体化合物V.4的制备
Figure PCTCN2022104612-appb-000024
向20毫升DMF中加入2.00克(3.38毫摩尔)3-氨基-2-氟-N-(2-碘-4-(全氟丙烷-2-基)-6-(三氟甲基)苯基)苯甲酰胺(参照WO2011093415或WO2010018714报道的方法制得)及0.30克(3.81毫摩尔)碘化钠，搅拌下滴加0.41克(3.42毫摩尔)溴丙烯，室温反应。TLC检测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.60克，即中间体化合物V.4。中间体化合物V.4的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.35(d,1H),8.30(d,1H),7.93(d,1H),7.40(td,1H),7.15(t,1H),6.92(td,1H),6.02–5.92(m,1H),5.34(dd,1H),5.24(dd,1H),4.26(s,1H),3.88(d,2H)。LC-MS(m/z,ESI):633.07(M+H) +。
实施例4：中间体化合物V.9的制备
Figure PCTCN2022104612-appb-000025
向10毫升DMF中加入1.00克(1.84毫摩尔)3-氨基-N-(2-溴-4-(全氟丙-2-基)-6-(三氟甲基)苯基)-2-氟苯甲酰胺及0.31克(2.07毫摩尔)碘化钠，搅拌下滴加0.22克(1.87毫摩尔)溴丙炔，升温至40度反应。TLC检测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.26克，即中间体化合物V.9。中间体化合物V.9的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.24(d,1H),8.14(d,1H),7.91(d,1H),7.51–7.45(m,1H),7.21(t,1H),7.05(td,1H),4.41–4.34(m,1H),4.05(dd,2H),2.28(t,1H)。LC-MS(m/z,ESI):583.06(M+H) +。
实施例5：中间体化合物V.10的制备
Figure PCTCN2022104612-appb-000026
向10毫升DMF中加入1.00克(1.69毫摩尔)3-氨基-2-氟-N-(2-碘-4-(全氟丙烷-2-基)-6-(三氟甲基)苯基)苯甲酰胺及0.30克(2.00毫摩尔)碘化钠，搅拌下滴加0.20 克(1.70毫摩尔)溴丙炔，升温至40度反应。TLC检测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.31克，即中间体化合物V.10。中间体化合物V.10的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.35(d,1H),8.28(d,1H),7.96–7.92(m,1H),7.49(td,1H),7.22(t,1H),7.05(td,1H),4.38(s,1H),4.08–4.03(m,2H),2.28(t,1H)。LC-MS(m/z,ESI):631.05(M+H) +。
实施例6：化合物7的制备
Figure PCTCN2022104612-appb-000027
向10毫升甲苯中加入0.15克(0.26毫摩尔)中间体V.3及0.04克(0.27毫摩尔)碘化钠、0.04克(0.25毫摩尔)对氟苯甲酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得白色固体0.13克，即化合物7。化合物7的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.12(d,1H),8.07–7.95(m,2H),7.89(d,1H),7.51–7.44(m,1H),7.36(s,2H),7.32–7.25(m,1H),6.90(s,2H),6.06–5.92(m,1H),5.26–5.15(m,2H),4.50(d,2H)。LC-MS(m/z,ESI):707.04(M+H) +。
实施例7：化合物8的制备
Figure PCTCN2022104612-appb-000028
向10毫升甲苯中加入0.15克(0.24毫摩尔)中间体V.4及0.04克(0.27毫摩尔)碘化钠、0.04克(0.25毫摩尔)对氟苯甲酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得白色固体0.11克，即化合物8。化合物8的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.33(d,1H),8.11–7.98(m,2H),7.94– 7.89(m,1H),7.48(dt,1H),7.36(s,2H),7.29(t,1H),6.90(s,2H),6.07–5.90(m,1H),5.26–5.15(m,2H),4.52(d,2H)。LC-MS(m/z,ESI):755.07(M+H) +。
实施例8：化合物19的制备
Figure PCTCN2022104612-appb-000029
向10毫升甲苯中加入0.15克(0.26毫摩尔)中间体V.3及0.06克(0.40毫摩尔)碘化钠、0.06克(0.38毫摩尔)6-氟烟酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得黄色油状物0.14克，即化合物19。化合物19的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.18(s,1H),8.13(d,1H),8.08–8.02(m,1H),8.01–7.79(m,3H),7.54–7.48(m,1H),7.34(t,1H),6.83(s,1H),6.05–5.91(m,1H),5.27–5.18(m,2H),4.53(d,2H)。LC-MS(m/z,ESI):708.05(M+H) +。
实施例9：化合物20的制备
Figure PCTCN2022104612-appb-000030
向10毫升甲苯中加入0.15克(0.24毫摩尔)中间体V.4及0.05克(0.33毫摩尔)碘化钠、0.05克(0.31毫摩尔)6-氟烟酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得白色固体0.09克，即化合物20。化合物20的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.35–8.31(m,1H),8.19(s,1H),8.09–8.03(m,1H),8.02–7.79(m,3H),7.52(dt,1H),7.35(t,1H),6.83(s,1H),6.05–5.93(m,1H),5.28–5.19(m,2H),4.53(d,2H)。LC-MS(m/z,ESI):756.05(M+H) +。
实施例10：化合物31的制备
方法一：
Figure PCTCN2022104612-appb-000031
向10毫升甲苯中加入0.15克(0.26毫摩尔)中间体V.9及0.04克(0.27毫摩尔)碘化钠、0.04克(0.29毫摩尔)苯甲酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得黄色油状物0.09克，即化合物31。化合物31的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.13(d,1H),8.09–7.95(m,2H),7.92–7.88(m,1H),7.63–7.53(br,1H),7.43–7.14(m,6H),4.93(s,1H),4.51(s,1H),2.30(t,1H)。LC-MS(m/z,ESI):687.07(M+H) +。
方法二：
Figure PCTCN2022104612-appb-000032
向10毫升甲苯中加入0.22克(0.68毫摩尔)中间体II.7及0.44克(3.70毫摩尔)氯化亚砜，加热回流4小时；减压脱溶，得中间体2-氟-3-(N-(丙-2-炔-1-基)苯甲酰胺基)苯甲酰氯密封备用。
向10毫升乙腈中加入上述制备的中间体2-氟-3-(N-(丙-2-炔-1-基)苯甲酰胺基)苯甲酰氯及0.08克(0.78毫摩尔)溴化钠、0.30克(0.74毫摩尔)2-溴-4-(全氟丙烷-2-基)-6-(三氟甲基)苯胺(参照WO2011093415或WO2010018714报道的方法制得)，加热回流；TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得白色固体0.23克，即化合物31。化合物31的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.13(d,1H),8.09–7.95(m,2H),7.92–7.88(m,1H),7.63–7.53(br,1H),7.43–7.14(m,6H),4.93(s,1H),4.51(s,1H),2.30(t,1H)。LC-MS(m/z,ESI):687.07(M+H) +。
方法三：
Figure PCTCN2022104612-appb-000033
(1)中间体化合物VI.7的制备
向10毫升乙腈中加入0.29克(0.68毫摩尔)中间体2-氟-3-(N-(丙-2-炔-1-基)苯甲酰胺基)苯甲酰氯及0.09克(0.87毫摩尔)溴化钠、0.30克(0.91毫摩尔)4-(全氟丙烷-2-基)-2-(三氟甲基)苯胺(参照WO2011093415或WO2010018714报道的方法制得)，加热回流。TLC检测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.39克，即中间体化合物VI.7。
(2)化合物31的制备
向10毫升N,N-二甲基甲酰胺中加入0.30克(0.49毫摩尔)中间体VI.7及0.02克(0.50毫摩尔)氢化钠(60％质量分数)、0.10克(0.56毫摩尔)N-溴代丁二酰亚胺，升温至40度反应。TLC检测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.06克，即化合物31。化合物31的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.13(d,1H),8.09–7.95(m,2H),7.92–7.88(m,1H),7.63–7.53(br,1H),7.43–7.14(m,6H),4.93(s,1H),4.51(s,1H),2.30(t,1H)。LC-MS(m/z,ESI):687.07(M+H) +。
方法四：
Figure PCTCN2022104612-appb-000034
向10毫升二氯甲烷中加入0.50克(0.82毫摩尔)中间体VI.7及0.12克(1.17毫摩尔)溴化钠、0.02克(0.50毫摩尔)氢氧化钠及0.21克的水，升温至40度；将0.64克(1.21毫摩尔)次氯酸钠水溶液(14％质量分数)滴加到反应溶液中，继续40度反应。TLC检测反应完毕后，加入水和乙酸乙酯萃取，有机相减压脱溶，残余物柱层析纯化，得白色固体0.23克，即化合物31。化合物31的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.13(d,1H),8.09–7.95(m,2H),7.92– 7.88(m,1H),7.63–7.53(br,1H),7.43–7.14(m,6H),4.93(s,1H),4.51(s,1H),2.30(t,1H)。LC-MS(m/z,ESI):687.07(M+H) +。
实施例11：化合物36的制备
Figure PCTCN2022104612-appb-000035
向10毫升甲苯中加入0.15克(0.24毫摩尔)中间体V.10及0.04克(0.27毫摩尔)碘化钠、0.04克(0.25毫摩尔)对氟苯甲酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得黄色油状物0.13克，即化合物36。化合物36的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.34(d,1H),8.19–8.01(m,2H),7.98–7.89(m,1H),7.60(t,1H),7.47–7.36(br s,2H),7.33(t,1H),7.03–6.83(br s,2H),4.90(s,1H),4.53(s,1H),2.31(t,1H)。LC-MS(m/z,ESI):753.04(M+H) +。
实施例12：化合物47的制备
Figure PCTCN2022104612-appb-000036
向10毫升甲苯中加入0.15克(0.26毫摩尔)中间体V.9及0.06克(0.40毫摩尔)碘化钠、0.06克(0.38毫摩尔)6-氟烟酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得白色固体0.09克，即化合物47。化合物47的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.22(s,1H),8.13(d,1H),8.12–8.08(m,1H),8.03(d,1H),7.94–7.81(m,2H),7.62(t,1H),7.37(t,1H),6.85(d,1H),4.90(s,1H),4.54(s,1H),2.39–2.26(m,1H)。LC-MS(m/z,ESI):706.03(M+H) +。
实施例13：化合物48的制备
Figure PCTCN2022104612-appb-000037
向10毫升甲苯中加入0.15克(0.24毫摩尔)中间体V.10及0.05克(0.33毫摩尔)碘化钠、0.06克(0.38毫摩尔)6-氟烟酰氯，加热回流。TLC检测反应完毕后，减压脱溶，残余物柱层析纯化，得黄色油状物0.09克，即化合物48。化合物48的核磁及质谱数据如下：
1H NMR(600MHz,Chloroform-d)δ8.34(d,1H),8.22(s,1H),8.14–7.99(m,2H),7.96–7.90(m,1H),7.86(s,1H),7.69–7.59(m,1H),7.38(t,1H),6.84(d,1H),4.90(s,1H),4.55(s,1H),2.33(t,1H)。LC-MS(m/z,ESI):754.05(M+H) +。
参照以上实施例可以制备本发明通式I～VII中其它化合物。
本发明部分化合物的物化性质、核磁及质谱数据如下：
化合物3：
Figure PCTCN2022104612-appb-000038
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.12(d,1H),7.98(t,1H),7.89(d,1H),7.46(t,1H),7.42–7.11(m,7H),6.07–5.93(br s,1H),5.27–5.15(m,2H),4.53(d,3H)。LC-MS(m/z,ESI):689.10(M+H) +。
化合物4：
Figure PCTCN2022104612-appb-000039
黄色固体。 1H NMR(600MHz,Chloroform-d)δ8.32(d,1H),7.98(t,1H),7.92(d,1H),7.51–7.44(m,1H),7.43–7.10(m,7H),6.10–5.90(br s,1H),5.28–5.14(m,2H),4.54(d,2H)。LC-MS(m/z,ESI):737.07(M+H) +。
化合物11：
Figure PCTCN2022104612-appb-000040
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.13(d,1H),8.03(t,1H),7.99–7.86(m,2H),7.67–7.37(m,5H),7.30(t,1H),6.07–5.89(br,1H),5.29–5.16(m,2H),4.54(d,2H)。LC-MS(m/z,ESI):714.11(M+H) +。
化合物12：
Figure PCTCN2022104612-appb-000041
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.34(d,1H),8.10–7.90(m,3H),7.61–7.37(m,5H),7.31(t,1H),6.06–5.91(br,1H),5.29–5.17(m,2H),4.54(d,2H)。LC-MS(m/z,ESI):762.05(M+H) +。
化合物23：
Figure PCTCN2022104612-appb-000042
油状物。 1H NMR(600MHz,Chloroform-d)δ8.62(s,1H),8.13(d,1H),8.06(t,1H),7.97–7.89(m,2H),7.82(d,1H),7.58(d,1H),7.51(t,1H),7.35(t,1H),6.07–5.89(m,1H),5.28–5.21(m,2H),4.55(d,2H)。LC-MS(m/z,ESI):715.11(M+H) +。
化合物24：
Figure PCTCN2022104612-appb-000043
黄色固体。 1H NMR(600MHz,Chloroform-d)δ8.62(s,1H),8.36–8.31(m,1H),8.07(t,1H),8.01–7.89(m,2H),7.82(d,1H),7.58(d,1H),7.52(d,1H),7.36(t,1H),6.06–5.90(m,1H),5.30–5.19(m,2H),4.56(d,2H)。LC-MS(m/z,ESI):763.04(M+H) +。
化合物27：
Figure PCTCN2022104612-appb-000044
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.64(s,1H),8.15–8.10(m,1H),8.07(t,1H),7.97–7.84(m,3H),7.64–7.50(m,2H),7.36(t,1H),6.07–5.92(br,1H),5.29–5.20(m,2H),4.57(s,2H)。LC-MS(m/z,ESI):758.09(M+H) +。
化合物28：
Figure PCTCN2022104612-appb-000045
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.65(s,1H),8.32(s,1H),8.07(t,1H),8.02–7.80(m,3H),7.64–7.50(m,2H),7.37(t,1H),6.07–5.92(br,1H),5.29–5.21(m,2H),4.57(s,2H)。LC-MS(m/z,ESI):806.08(M+H) +。
化合物32：
Figure PCTCN2022104612-appb-000046
油状物。 1H NMR(600MHz,Chloroform-d)δ8.35–8.31(m,1H),8.17–7.96(m,2H),7.95–7.90(m,1H),7.63–7.55(br,1H),7.51–7.04(m,6H),4.93(s,1H),4.52(s,1H),2.30(t,1H)。LC-MS(m/z,ESI):735.06(M+H) +。
化合物35：
Figure PCTCN2022104612-appb-000047
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.13(d,1H),8.11–7.99(m,2H),7.93–7.88(m,1H),7.63–7.54(m,1H),7.47–7.35(m,2H),7.32(t,1H),7.02–6.82(br,2H),4.89(s,1H),4.51(s,1H),2.30(t,1H)。LC-MS(m/z,ESI):705.04(M+H) +。
化合物39：
Figure PCTCN2022104612-appb-000048
油状物。 1H NMR(600MHz,Chloroform-d)δ8.14(d,1H),8.09(t,1H),8.05–7.95(br s,1H),7.91(d,1H),7.72–7.38(m,5H),7.34(t,1H),4.93(s,1H),4.52(s,1H),2.33(s,1H)。LC-MS(m/z,ESI):712.07(M+H) +。
化合物40：
Figure PCTCN2022104612-appb-000049
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.34(d,1H),8.19–7.97(m,2H),7.93(d,1H),7.72–7.39(m,5H),7.34(t,1H),4.94(s,1H),4.53(s,1H),2.33(s,1H)。LC-MS(m/z,ESI):760.04(M+H) +。
化合物51：
Figure PCTCN2022104612-appb-000050
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.64(s,1H),8.16–8.08(m,2H),7.97(d,1H),7.91(d,1H),7.85(s,1H),7.68–7.56(m,2H),7.38(t,1H),4.93(d,1H),4.55(d,1H),2.35(s,1H)。LC-MS(m/z,ESI):735.05(M+Na) +。
化合物52：
Figure PCTCN2022104612-appb-000051
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.64(s,1H),8.34(d,1H),8.12(t,1H),8.07–7.96(m,1H),7.93(d,1H),7.84(s,1H),7.70–7.54(m,2H),7.39(t,1H),4.93(d,1H),4.56(d,1H),2.35(s,1H)。LC-MS(m/z,ESI):761.00(M+H) +。
化合物55：
Figure PCTCN2022104612-appb-000052
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.67(s,1H),8.17–8.07(m,2H),8.03–7.85(m,3H),7.70–7.55(m,2H),7.43–7.34(m,1H),4.93(d,1H),4.58(d,1H),2.35(s,1H)。LC-MS(m/z,ESI):756.09(M+H) +。
化合物56：
Figure PCTCN2022104612-appb-000053
白色固体。 1H NMR(600MHz,Chloroform-d)δ8.67(s,1H),8.36–8.31(m,1H),8.12(t,1H),8.00(d,1H),7.95–7.85(m,2H),7.68(t,1H),7.63–7.55(m,1H),7.40(t,1H),4.93(d,1H),4.59(d,1H),2.35(s,1H)。LC-MS(m/z,ESI):804.07(M+H) +。
生物活性测定
实施例14：杀虫生物活性测定
用本发明化合物对几种昆虫进行了杀虫活性测定实验。测定方法如下：
待测化合物用丙酮/甲醇(1:1)的混合溶剂溶解后，用含有0.1％(wt)吐温80的水稀释至所需的浓度。
以粘虫、小菜蛾、二化螟、甜菜夜蛾、桃蚜、西花蓟马为靶标，采用Airbrush喷雾法进行活性测定。
(1)杀粘虫的活性测定
测定方法：将玉米叶片剪成长2cm的叶段，Airbrush喷雾处理的压力为10psi(约合0.7kg/cm 2)，每叶段正反面喷雾，待测化合物的喷液量为0.5mL。阴干后每处理接入10头3龄幼虫，每处理3次重复。处理后放入25℃、相对湿度60～70％观察室内培养，药后3天后调查存活虫数，计算死亡率。
对粘虫的部分测试结果如下：
在0.05mg/L剂量下，药后3天，化合物3、4、7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56对粘虫的致死率在90％以上。
(2)杀小菜蛾的活性测定
测定方法：将甘蓝叶片用打孔器打成直径2cm的叶碟，Airbrush喷雾处理的压力为10psi(约合0.7kg/cm 2)，每叶碟正反面喷雾，待测化合物的喷液量为0.5mL。阴干后每处理接入10头3龄幼虫，每处理3次重复。处理后放入25℃、相对湿度60～70％观察室内培养，药后3天调查存活虫数，计算死亡率。
对小菜蛾的部分测试结果如下：
在1.25mg/L剂量下，化合物3、4、7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56对小菜蛾的致死率在90％以上。
按照以上试验方法，进一步的选取本发明部分化合物与对照化合物KC1、KC2、KC9、KC10对小菜蛾活性进行平行测定，试验结果见表12。
表12本发明部分化合物与对照化合物KC1、KC2、KC9、KC10对小菜蛾杀虫活性平行比较试验
Figure PCTCN2022104612-appb-000054
Figure PCTCN2022104612-appb-000055
Figure PCTCN2022104612-appb-000056
注：表中KC9、KC10为本申请另外提供的对照化合物，参照本发明实施例10的方法可以获得，原料均为按照本发明实施例方法可以制备得到的或可以购买得到的或按照常规方法可以制得。
通过将本发明化合物和对照化合物KC1、KC2、KC9、KC10进行比较、通过将KC9和KC1进行比较、通过将KC10和KC2进行比较可知：相比于现有技术，本发明化合物具有意想不到的高杀虫活性及实质意义上的进步。
按照以上试验方法，进一步的选取本发明化合物3、7、8、19、20、31、35、36、47、48与对照化合物KC3、KC4、KC5、KC6、KC7、KC8对小菜蛾活性进行平行测定，试验结果见表13。
表13本发明部分化合物与对照化合物对小菜蛾杀虫活性平行比较试验
Figure PCTCN2022104612-appb-000057
Figure PCTCN2022104612-appb-000058
如表13所示，通过将化合物3、31和对照化合物KC3进行比较、通过将化合物7、35和对照化合物KC4进行比较、通过将化合物8、36和对照化合物KC5进行比较、通过将化合物19、47和对照化合物KC7进行比较、通过将化合物20、48和对照化合物KC6、KC8进行比较可以看出：本发明实施例中通过对式I化合物 中的R 2引入了烯丙基和炔丙基，相比于现有技术，获得了杀虫效果更好的化合物。
(3)杀二化螟的活性测定
测定方法：1)稻苗准备：在恒温室(温度26～28℃、相对湿度60～80％左右，光照16hL:8hD)内用直径为4.5cm、高4cm塑料小杯培养水稻，待水稻长至4～5叶期时，选择健壮的、长势一致的水稻幼苗进行药剂处理，每处理设3次重复。2)试虫准备：室内连续饲养的二化螟，3龄幼虫。3)稻茎喷雾接虫。采用喷雾法，对稻苗进行全株均匀喷雾处理，每处理用药15mL。先处理空白对照，然后按试验浓度由低到高的顺序重复上述操作。稻苗喷雾处理后，放置阴凉处将药液晾干，剪取茎基部上5厘米左右茎秆饲喂试虫。准备直径90mm的玻璃培养皿，皿底垫滤纸，加水保湿，每皿放入约5根稻茎，接幼虫10头，用无纺布密闭培养皿，置于恒温房间培养。药后3天调查残留活虫数。
对二化螟的部分测试结果如下：
在0.625mg/L剂量下，化合物3、4、7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56对二化螟的致死率在90％以上。
(4)杀甜菜夜蛾的活性测定
测定方法：采用浸叶碟饲喂法进行活性测试。将叶碟浸入药液中10s，晾干后置于培养皿中，每皿4碟，培养皿内放滤纸保湿。每皿接甜菜夜蛾试虫10头，3次重复。置于光照培养箱内，温度25℃，光照14hL:10hD，培养。药后1天、2天、3天调查甜菜夜蛾死虫数，计算死亡率。
对甜菜夜蛾的测试结果如下：
在0.625mg/L剂量下，药后3天，化合物3、4、7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56对甜菜夜蛾的致死率为90％以上。
(5)杀桃蚜的活性测定
测定方法：取直径6cm培养皿，皿底覆一层滤纸，并滴加适量自来水保湿。从培养桃蚜的甘蓝植株上剪取大小适宜(直径约3cm)且长有15～30头蚜虫的甘蓝叶片，去除有翅蚜及叶片正面的蚜虫，叶背向上置于培养皿内。airbrush喷雾 处理的压力为10psi(约合0.7kg/cm2)，喷液量为0.5mL，每处理3次重复。处理后放入25℃、相对湿度60～70％观察室内培养，48小时后调查存活虫数，计算死亡率。
对桃蚜的测试结果如下：
在50mg/L剂量下，化合物3、4、7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56对桃蚜的致死率为90％以上。
(6)杀西花蓟马的活性测定
测定方法：选温室栽培的新鲜菜豆叶片，用手持式Airbrush喷雾器均匀喷雾，每处理1mL，自然阴干后置于指形管中，接入整齐、健康的西花蓟马若虫，每处理15头，试验设3次重复，设水处理为空白对照。处理后放入24℃、相对湿度60％-70％、自然光照的室内培养，72小时后调查存活虫数，计算死亡率。
对西花蓟马的测试结果如下：
在100mg/L剂量下，化合物3、4、7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56对西花蓟马的致死率为90％以上。
按照以上试验方法，进一步的选取本发明化合物3、7、8、19、20、31、35、36、47、48与对照化合物KC3、KC4、KC5、KC6、KC7、KC8对西花蓟马若虫活性进行平行测定，试验结果见表14。
表14本发明部分化合物与对照化合物对西花蓟马若虫杀虫活性平行比较试验
Figure PCTCN2022104612-appb-000059
Figure PCTCN2022104612-appb-000060
Figure PCTCN2022104612-appb-000061
如表14所示，通过将化合物3、31和对照化合物KC3进行比较、通过将化合物7、35和对照化合物KC4进行比较、通过将化合物8、36和对照化合物KC5进行比较、通过将化合物19、47和对照化合物KC7进行比较、通过将化合物20、48和对照化合物KC6、KC8进行比较可以看出：本发明实施例中通过对式I化合物中的R 2引入了烯丙基和炔丙基，相比于现有技术，获得了杀虫效果更好的化合物。
实施例15：对猫蚤的杀虫试验
将4mg待测化合物溶解于40mL丙酮，获得浓度100mg/L的丙酮溶液，在内径5.3cm的培养皿的底面和侧面上涂布400μL药液，然后待丙酮挥发，在培养皿的内壁上制作本发明化合物的薄膜。所使用的培养皿的内壁为40cm 2，处理药量为1μg/cm 2；向其中放入10只猫蚤成虫(雌雄混合)，盖好后在25℃的恒温室内保存。检查72h后的死虫数，计算死虫率。试验按3次重复进行。测试结果：化合物3、4、7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56显示出90％以上的死虫率。
实施例16：对美洲犬蜱的杀虫试验
将4mg待测化合物溶解于40mL丙酮，获得浓度100mg/L的丙酮溶液，在2个内径5.3cm的培养皿的底面和侧面上，涂布400μL药液，然后待丙酮挥发，在培养皿的内壁上制作本发明化合物的薄膜。所使用的培养皿的内壁为40cm 2，处理药量为1μg/cm 2。向其中放入10只美洲犬蜱的第1若虫(雌雄混合)，合并2个培养皿，使用胶带密封结合部以防止逃亡，在25℃的恒温室中保存。检查24h后的死虫数，计算死虫率。试验按3次重复进行。测试结果：化合物3、4、 7、8、11、12、19、20、23、24、27、28、31、32、35、36、39、40、47、48、51、52、55、56显示出90％以上的死虫率。

Claims (36)

  1. 一种酰胺类化合物，其特征在于：所述酰胺类化合物的结构如通式I所示：
    Figure PCTCN2022104612-appb-100001
    通式I中：
    R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
    R 2选自烯丙基或炔丙基；
    R 3选自卤素；
    R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基；
    X选自CH或N。
  2. 根据权利要求1所述的酰胺类化合物，其特征在于：通式I中，
    R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
    R 2选自烯丙基或炔丙基；
    R 3选自溴或碘；
    R 4选自溴、碘、三氟甲基或二氟甲氧基；
    X选自CH或N。
  3. 根据权利要求2所述的酰胺类化合物，其特征在于，酰胺类化合物选自：
    表1化合物，表1化合物具有如通式I的结构且R 1,X,R 2,R 3和R 4如表1中所示；
    表1
    Figure PCTCN2022104612-appb-100002
    Figure PCTCN2022104612-appb-100003
    Figure PCTCN2022104612-appb-100004
  4. 根据权利要求3所述的酰胺类化合物，其特征在于，酰胺类化合物选自：
    表2化合物，表2化合物具有如通式I的结构且R 1,X,R 2,R 3和R 4如表2中所示；
    表2
    Figure PCTCN2022104612-appb-100005
    Figure PCTCN2022104612-appb-100006
    Figure PCTCN2022104612-appb-100007
  5. 根据权利要求4所述的酰胺类化合物，其特征在于，酰胺类化合物选自：
    表3化合物，表3化合物具有如通式I的结构且R 1,X,R 2,R 3和R 4如表3中所示；
    表3
    Figure PCTCN2022104612-appb-100008
  6. 一种化合物，所述化合物为制备如权利要求1-5中任一项所述酰胺类化合物的 中间体，其特征在于，所述化合物具有如下通式II所示结构：
    Figure PCTCN2022104612-appb-100009
    通式II中：
    R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
    R 2选自烯丙基或炔丙基；
    X选自CH或N。
  7. 根据权利要求6所述的化合物，其特征在于，所述化合物选自：
    表4化合物，表4化合物具有如通式II的结构且R 1,X和R 2如表4中所示；
    表4
    化合物编号 R 1 X R 2 II.1 H CH 烯丙基 II.2 F CH 烯丙基 II.3 CN CH 烯丙基 II.4 F N 烯丙基 II.5 CN N 烯丙基 II.6 CF 3 N 烯丙基 II.7 H CH 炔丙基 II.8 F CH 炔丙基 II.9 CN CH 炔丙基 II.10 F N 炔丙基 II.11 CN N 炔丙基 II.12 CF 3 N 炔丙基
    。
  8. 一种化合物，所述化合物为制备如权利要求6-7中任一项所述化合物的中间体，其特征在于，所述化合物具有如下通式III所示结构：
    Figure PCTCN2022104612-appb-100010
    通式III中：
    R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
    X选自CH或N；
    R 2选自烯丙基或炔丙基；
    R 5选自C 1-C 6烷基。
  9. 根据权利要求8所述的化合物，其特征在于，所述化合物选自：
    表5化合物，表5化合物具有如通式III的结构且R 1,X,R 2和R 5如表5中所示；
    表5
    化合物编号 R 1 X R 2 R 5 III.1 H CH 烯丙基 CH 3 III.2 F CH 烯丙基 CH 3 III.3 CN CH 烯丙基 CH 3 III.4 F N 烯丙基 CH 3 III.5 CN N 烯丙基 CH 3 III.6 CF 3 N 烯丙基 CH 3 III.7 H CH 炔丙基 CH 3 III.8 F CH 炔丙基 CH 3 III.9 CN CH 炔丙基 CH 3 III.10 F N 炔丙基 CH 3 III.11 CN N 炔丙基 CH 3 III.12 CF 3 N 炔丙基 CH 3 III.13 H CH 烯丙基 CH 2CH 3 III.14 F CH 烯丙基 CH 2CH 3 III.15 CN CH 烯丙基 CH 2CH 3 III.16 F N 烯丙基 CH 2CH 3 III.17 CN N 烯丙基 CH 2CH 3 III.18 CF 3 N 烯丙基 CH 2CH 3 III.19 H CH 炔丙基 CH 2CH 3 III.20 F CH 炔丙基 CH 2CH 3 III.21 CN CH 炔丙基 CH 2CH 3 III.22 F N 炔丙基 CH 2CH 3 III.23 CN N 炔丙基 CH 2CH 3 III.24 CF 3 N 炔丙基 CH 2CH 3
    。
  10. 一种化合物，所述化合物为制备如权利要求8-9中任一项所述化合物的中间体，其特征在于，所述化合物具有如下通式IV所示结构：
    Figure PCTCN2022104612-appb-100011
    通式IV中：
    R 2选自烯丙基或炔丙基；
    R 5选自C 1-C 6烷基。
  11. 根据权利要求10所述的化合物，其特征在于，所述化合物选自：
    表6化合物，表6化合物具有如通式IV的结构且R 2和R 5如表6中所示；
    表6
    化合物编号 R 2 R 5 IV.1 烯丙基 CH 3 IV.2 烯丙基 CH 2CH 3 IV.3 烯丙基 CH 2CH 2CH 3 IV.4 烯丙基 CH 2CH 2CH 2CH 3 IV.5 烯丙基 CH 2CH 2CH 2CH 2CH 3 IV.6 烯丙基 CH 2CH 2CH 2CH 2CH 2CH 3 IV.7 炔丙基 CH 3 IV.8 炔丙基 CH 2CH 3 IV.9 炔丙基 CH 2CH 2CH 3 IV.10 炔丙基 CH 2CH 2CH 2CH 3 IV.11 炔丙基 CH 2CH 2CH 2CH 2CH 3 IV.12 炔丙基 CH 2CH 2CH 2CH 2CH 2CH 3
    。
  12. 一种化合物，所述化合物为制备如权利要求1-5中任一项所述酰胺类化合物的中间体，其特征在于，所述化合物具有如下通式V所示结构：
    Figure PCTCN2022104612-appb-100012
    通式V中：
    R 2选自烯丙基或炔丙基；
    R 3选自卤素；
    R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基。
  13. 根据权利要求12所述的化合物，其特征在于，通式V中，
    R 2选自烯丙基或炔丙基；
    R 3选自溴或碘；
    R 4选自溴、碘、三氟甲基或二氟甲氧基。
  14. 根据权利要求13所述的化合物，其特征在于，所述化合物选自：
    表7化合物，表7化合物具有如通式V的结构且R 2,R 3和R 4如表7中所示；
    表7
    化合物编号 R 2 R 3 R 4 V.1 烯丙基 Br Br V.2 烯丙基 Br I V.3 烯丙基 Br CF 3 V.4 烯丙基 I CF 3 V.5 烯丙基 Br OCHF 2 V.6 烯丙基 I OCHF 2 V.7 炔丙基 Br Br V.8 炔丙基 Br I V.9 炔丙基 Br CF 3 V.10 炔丙基 I CF 3 V.11 炔丙基 Br OCHF 2 V.12 炔丙基 I OCHF 2
    。
  15. 根据权利要求14所述的化合物，其特征在于，所述化合物选自：
    表8化合物，表8化合物具有如通式V的结构且R 2,R 3和R 4如表8中所示；
    表8
    化合物编号 R 2 R 3 R 4 V.3 烯丙基 Br CF 3 V.4 烯丙基 I CF 3 V.9 炔丙基 Br CF 3 V.10 炔丙基 I CF 3
    。
  16. 一种化合物，所述化合物为制备如权利要求1-5中任一项所述酰胺类化合物的中间体，其特征在于，所述化合物具有如下通式VI所示结构：
    Figure PCTCN2022104612-appb-100013
    通式VI中：
    R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
    R 2选自烯丙基或炔丙基；
    R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基；
    X选自CH或N。
  17. 根据权利要求16所述的化合物，其特征在于：通式VI中，
    R 1选自氢、氟、氰基、三氟甲基或二氟甲基；
    R 2选自烯丙基或炔丙基；
    R 4选自溴、碘、三氟甲基或二氟甲氧基；
    X选自CH或N。
  18. 根据权利要求17所述的化合物，其特征在于，所述化合物选自：
    表9化合物，表9化合物具有如通式VI的结构且R 1,X,R 2和R 4如表9中所示；
    表9
    化合物编号 R 1 X R 2 R 4 VI.1 H CH 烯丙基 CF 3 VI.2 F CH 烯丙基 CF 3 VI.3 CN CH 烯丙基 CF 3 VI.4 F N 烯丙基 CF 3 VI.5 CN N 烯丙基 CF 3 VI.6 CF 3 N 烯丙基 CF 3 VI.7 H CH 炔丙基 CF 3 VI.8 F CH 炔丙基 CF 3 VI.9 CN CH 炔丙基 CF 3 VI.10 F N 炔丙基 CF 3 VI.11 CN N 炔丙基 CF 3 VI.12 CF 3 N 炔丙基 CF 3 VI.13 H CH 烯丙基 OCHF 2 VI.14 F CH 烯丙基 OCHF 2 VI.15 CN CH 烯丙基 OCHF 2 VI.16 F N 烯丙基 OCHF 2 VI.17 CN N 烯丙基 OCHF 2 VI.18 CF 3 N 烯丙基 OCHF 2 VI.19 H CH 炔丙基 OCHF 2 VI.20 F CH 炔丙基 OCHF 2 VI.21 CN CH 炔丙基 OCHF 2 VI.22 F N 炔丙基 OCHF 2 VI.23 CN N 炔丙基 OCHF 2 VI.24 CF 3 N 炔丙基 OCHF 2
    。
  19. 根据权利要求18所述的化合物，其特征在于，所述化合物选自：
    表10化合物，表10化合物具有如通式VI的结构且R 1,X,R 2和R 4如表10中所示；
    表10
    化合物编号 R 1 X R 2 R 4 VI.1 H CH 烯丙基 CF 3 VI.2 F CH 烯丙基 CF 3 VI.3 CN CH 烯丙基 CF 3 VI.4 F N 烯丙基 CF 3 VI.5 CN N 烯丙基 CF 3 VI.6 CF 3 N 烯丙基 CF 3 VI.7 H CH 炔丙基 CF 3 VI.8 F CH 炔丙基 CF 3 VI.9 CN CH 炔丙基 CF 3 VI.10 F N 炔丙基 CF 3 VI.11 CN N 炔丙基 CF 3 VI.12 CF 3 N 炔丙基 CF 3
    。
  20. 一种化合物，所述化合物为制备如权利要求16-19中任一项所述化合物的中间体，其特征在于，所述化合物具有如下通式VII所示结构：
    Figure PCTCN2022104612-appb-100014
    通式VII中：
    R 2选自烯丙基或炔丙基；
    R 4选自卤素、C 1-C 3卤代烷基或C 1-C 3卤代烷氧基。
  21. 根据权利要求20所述的化合物，其特征在于：通式VII中，
    R 2选自烯丙基或炔丙基；
    R 4选自溴、碘、三氟甲基或二氟甲氧基。
  22. 根据权利要求21所述的化合物，其特征在于，所述化合物选自：
    表11化合物，表11化合物具有如通式VII的结构且R 2和R 4如表11中所示；
    表11
    化合物编号 R 2 R 4 VII.1 烯丙基 CF 3 VII.2 烯丙基 OCHF 2 VII.3 炔丙基 CF 3 VII.4 炔丙基 OCHF 2
    。
  23. 一种如权利要求1-5中任一项所述的酰胺类化合物的制备方法，其特征在于，所述制备方法包括采用如通式VI所示的中间体化合物与适宜的卤代试剂在适宜的溶剂中反应制得通式I化合物，化合物反应式如下：
    Figure PCTCN2022104612-appb-100015
  24. 如权利要求23所述的酰胺类化合物的制备方法，其特征在于，通式VI化合物与适宜的碱、卤代试剂在适宜的溶剂中，在温度从-10℃到溶剂沸点下反应0.5-48小时制得通式I化合物。
  25. 如权利要求23或24所述的酰胺类化合物的制备方法，其特征在于：
    适宜的卤代试剂选自氯气、液溴、碘、NBS、NCS、NIS、双氧水与氢溴酸的混合物、双氧水与氢碘酸的混合物、次氯酸钠与氢溴酸的混合物或次氯酸钠与氢碘酸的混合物；
    适宜的溶剂选自苯、甲苯、二甲苯、丙酮、甲乙酮、甲基异丁基酮、氯仿、二氯甲烷，乙酸甲酯、乙酸乙酯、四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷、水、乙腈、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二甲基亚砜或上述溶剂的混合溶剂；
    反应温度优选0℃-100℃；更优选25℃-80℃。
  26. 如权利要求24所述的酰胺类化合物的制备方法，其特征在于：
    适宜的碱选自三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶、N,N-二异丙基甲胺、N,N-二异丙基乙胺、氢化钠、氢化钾、氢氧化钠、氢氧化钾、氢氧化钙、碳酸钠、碳酸钾、碳酸氢钠、碳酸氢钾、甲醇钠、乙醇钠、乙醇钾、叔丁醇钾或叔丁醇钠；优选氢化钠、氢化钾、氢氧化钠或氢氧化钾。
  27. 一种根据权利要求1-5之一所述的酰胺类化合物在制备杀虫剂中的用途。
  28. 根据权利要求27所述的用途，其特征在于：所述杀虫剂用于防治小菜蛾、粘虫、甜菜夜蛾、斜纹夜蛾、二化螟、桃蚜、蓟马、跳甲中的一种或几种。
  29. 一种杀虫剂制剂，其特征在于：所述杀虫剂制剂中含有权利要求1-5之一所述的酰胺类化合物作为活性组分，还含有一种或多种辅料；可选地，杀虫剂制剂中权利要求1-5之一所述的酰胺类化合物的量为0.1至99重量％，进一步可选地为0.5至90重量％。
  30. 一种杀虫剂组合物，其特征在于：包括权利要求1-5之一所述的酰胺类化合物和其他活性化合物的混合物，所述其他活性化合物选自杀虫剂、毒饵剂、消毒剂、杀螨剂、杀线虫剂、杀真菌剂、生长调节剂、除草剂中的一种或多种。
  31. 一种控制农业或林业害虫的方法，其特征在于：将有效剂量的材料施用于需要控制的害虫或其生长介质上，所述材料选自下组中的一种或多种：
    权利要求1-5之一所述的酰胺类化合物；
    权利要求29所述的杀虫剂制剂；
    权利要求30所述的杀虫剂组合物。
  32. 一种根据权利要求1-5之一所述的酰胺类化合物在制备动物寄生虫防治剂中的用途。
  33. 根据权利要求32所述的用途，其特征在于：所述动物寄生虫防治剂用于防治猫蚤、美洲犬蜱中的一种或几种。
  34. 一种动物寄生虫防治剂，其特征在于：所述动物寄生虫防治剂中含有权利要求1-5之一所述的酰胺类化合物作为活性组分，还含有一种或多种辅料；可选地，动物寄生虫防治剂中权利要求1-5之一所述的酰胺类化合物的量为1至80重量％。
  35. 一种动物寄生虫防治组合物，其特征在于：包括权利要求1-5之一所述的酰胺类化合物和其他动物寄生虫防治活性化合物的混合物，所述其他动物寄生虫防治活性化合物选自杀螨剂、杀昆虫剂、杀寄生虫剂、抗疟原虫剂中的一种或多种。
  36. 一种控制动物寄生虫的方法，其特征在于：包括以下步骤：将有效剂量的材料施于需要控制的动物寄生虫或其生长介质上，所述材料选自下组中的一种或多种：
    权利要求1-5之一所述的酰胺类化合物；
    权利要求34所述的动物寄生虫防治剂；
    权利要求35所述的动物寄生虫防治组合物。
PCT/CN2022/104612 2021-07-12 2022-07-08 一种酰胺类化合物及其用途 WO2023284645A1 (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022310062A AU2022310062B2 (en) 2021-07-12 2022-07-08 Amide compound and use thereof
US18/410,006 US20240199552A1 (en) 2021-07-12 2024-01-11 Amide compound and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110782785.2 2021-07-12
CN202110782785 2021-07-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US18/410,006 Continuation US20240199552A1 (en) 2021-07-12 2024-01-11 Amide compound and use thereof

Publications (1)

Publication Number Publication Date
WO2023284645A1 true WO2023284645A1 (zh) 2023-01-19

Family

ID=84857128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/104612 WO2023284645A1 (zh) 2021-07-12 2022-07-08 一种酰胺类化合物及其用途

Country Status (4)

Country Link
US (1) US20240199552A1 (zh)
CN (1) CN115611767A (zh)
AU (1) AU2022310062B2 (zh)
WO (1) WO2023284645A1 (zh)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008044713A1 (fr) * 2006-10-10 2008-04-17 Nihon Nohyaku Co., Ltd. Dérivé de pyridinecarboxanilide substitué ou un de ses sels, agent agricole ou horticole et utilisation de celui-ci
CN102119143A (zh) * 2008-08-13 2011-07-06 三井化学Agro株式会社 酰胺衍生物、含有该酰胺衍生物的有害生物防除剂及其使用方法
US20200281914A1 (en) * 2017-09-20 2020-09-10 Mitsui Chemicals Agro, Inc. Prolonged ectoparasite-controlling agent for animal
CN111793008A (zh) * 2019-04-02 2020-10-20 沈阳化工大学 一种间二酰胺类化合物及其应用
CN112430211A (zh) * 2019-08-26 2021-03-02 沈阳化工大学 一种间苯二甲酰胺类化合物及其应用
CN114573547A (zh) * 2020-12-01 2022-06-03 东莞市东阳光农药研发有限公司 酰胺衍生物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002338537A (ja) * 2001-05-16 2002-11-27 Mitsubishi Pharma Corp アミド化合物およびその医薬用途
JP2007099761A (ja) * 2005-09-08 2007-04-19 Mitsui Chemicals Inc アミド誘導体ならびにその殺虫剤としての使用方法
KR101409076B1 (ko) * 2008-08-01 2014-06-18 미쓰이가가쿠 아그로 가부시키가이샤 아미드 유도체, 그 아미드 유도체를 함유하는 유해 생물 방제제 및 유해 생물의 방제 방법
EP2253617A1 (de) * 2009-05-20 2010-11-24 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
JP2011063549A (ja) * 2009-09-17 2011-03-31 Mitsui Chemicals Agro Inc アミド誘導体、および該アミド誘導体を含有する有害生物防除剤
JP2011157295A (ja) * 2010-01-29 2011-08-18 Mitsui Chemicals Agro Inc 植物種子用虫害防除組成物および虫害の予防方法
JP2011157296A (ja) * 2010-01-29 2011-08-18 Mitsui Chemicals Agro Inc 有害生物防除組成物
JP2011157294A (ja) * 2010-01-29 2011-08-18 Mitsui Chemicals Agro Inc 有害生物防除組成物
BR112015025028B1 (pt) * 2013-04-02 2020-10-13 Syngenta Participations Ag compostos, processo para a produção de compostos, métodos para controle de insetos, ácaros, nematódeos ou moluscos e para proteção de plantas úteis e composição
WO2019161495A1 (en) * 2018-02-20 2019-08-29 The Governors Of The University Of Alberta Ripk2 inhibitors
CN112457288B (zh) * 2019-09-06 2021-12-14 沈阳中化农药化工研发有限公司 一种胡椒酸衍生物及其应用

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008044713A1 (fr) * 2006-10-10 2008-04-17 Nihon Nohyaku Co., Ltd. Dérivé de pyridinecarboxanilide substitué ou un de ses sels, agent agricole ou horticole et utilisation de celui-ci
CN102119143A (zh) * 2008-08-13 2011-07-06 三井化学Agro株式会社 酰胺衍生物、含有该酰胺衍生物的有害生物防除剂及其使用方法
US20200281914A1 (en) * 2017-09-20 2020-09-10 Mitsui Chemicals Agro, Inc. Prolonged ectoparasite-controlling agent for animal
CN111793008A (zh) * 2019-04-02 2020-10-20 沈阳化工大学 一种间二酰胺类化合物及其应用
CN112430211A (zh) * 2019-08-26 2021-03-02 沈阳化工大学 一种间苯二甲酰胺类化合物及其应用
CN114573547A (zh) * 2020-12-01 2022-06-03 东莞市东阳光农药研发有限公司 酰胺衍生物及其制备方法和应用

Also Published As

Publication number Publication date
CN115611767A (zh) 2023-01-17
US20240199552A1 (en) 2024-06-20
AU2022310062A1 (en) 2024-02-22
AU2022310062B2 (en) 2024-10-17

Similar Documents

Publication Publication Date Title
AU2020338765B2 (en) Isophthalamide compound and use thereof
WO2021000867A1 (zh) 一种异噁唑啉类化合物及其应用
KR20120048006A (ko) 살해충성 카복사미드
JP2011136928A (ja) 殺虫性アリールピロリジン類
JP2010116389A (ja) 殺虫性アリールピロリジン類
JP2011093855A (ja) 殺虫性オキサゾリジノン誘導体
JP2011042643A (ja) 殺虫性カルボキサミド類
WO2021139370A1 (zh) 一种酰胺类化合物及其应用
JP2010254629A (ja) 光学活性アゾリン誘導体
WO2023284645A1 (zh) 一种酰胺类化合物及其用途
WO2023217077A1 (zh) 一种苯基吡唑类化合物及其应用
US20230203013A1 (en) Method for preparing 2-chloro-n-(1-cyanocyclopropyl)-5-[2'-methyl-5'-(pentafluoroethyl)-4'-(trifluoromethyl)-2'h-1,3'-bipyrazol-4-yl]benzamide
JP2014521592A (ja) 殺害虫性ジアリールヘテロ環誘導体
TW202120480A (zh) 用於控制節肢動物之新穎化合物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22841281

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: AU2022310062

Country of ref document: AU

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022310062

Country of ref document: AU

Date of ref document: 20220708

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 22841281

Country of ref document: EP

Kind code of ref document: A1